2023-11-23 20:28:49 - Transformer_NER - INFO - Task will use CPU.
2023-11-23 20:28:49 - Transformer_NER - WARNING - set tokenizer as bert-base-uncased
2023-11-23 20:28:49 - Transformer_NER - WARNING - set config as bert-base-uncased
2023-11-23 20:28:49 - Transformer_NER - ERROR - Traceback (most recent call last):
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\run_transformer_ner.py", line 169, in main
    run_task(global_args)
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\task.py", line 557, in run_task
    labels, label2idx = ner_data_processor.get_labels(default=args.model_type)
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\data_utils.py", line 96, in get_labels
    _, train_labels = self._read_data(self.data_dir / "train.txt", task='train')
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\data_utils.py", line 124, in _read_data
    with open(file_name, "r") as f:
FileNotFoundError: [Errno 2] No such file or directory: '\\trains\\train.txt'

2023-11-23 20:51:36 - Transformer_NER - INFO - Task will use CPU.
2023-11-23 20:51:36 - Transformer_NER - WARNING - set tokenizer as bert-base-uncased
2023-11-23 20:51:36 - Transformer_NER - WARNING - set config as bert-base-uncased
2023-11-23 20:51:36 - Transformer_NER - ERROR - Traceback (most recent call last):
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\run_transformer_ner.py", line 169, in main
    run_task(global_args)
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\task.py", line 557, in run_task
    labels, label2idx = ner_data_processor.get_labels(default=args.model_type)
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\data_utils.py", line 96, in get_labels
    _, train_labels = self._read_data(self.data_dir / "train.txt", task='train')
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\data_utils.py", line 124, in _read_data
    with open(file_name, "r") as f:
FileNotFoundError: [Errno 2] No such file or directory: '\\trains\\train.txt'

2023-11-23 20:51:52 - Transformer_NER - INFO - Task will use CPU.
2023-11-23 20:51:52 - Transformer_NER - WARNING - set tokenizer as bert-base-uncased
2023-11-23 20:51:52 - Transformer_NER - WARNING - set config as bert-base-uncased
2023-11-23 20:51:52 - Transformer_NER - ERROR - Traceback (most recent call last):
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\run_transformer_ner.py", line 169, in main
    run_task(global_args)
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\task.py", line 557, in run_task
    labels, label2idx = ner_data_processor.get_labels(default=args.model_type)
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\data_utils.py", line 96, in get_labels
    _, train_labels = self._read_data(self.data_dir / "train.txt", task='train')
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\data_utils.py", line 124, in _read_data
    with open(file_name, "r") as f:
FileNotFoundError: [Errno 2] No such file or directory: '\\merge\\train.txt'

2023-11-23 20:52:26 - Transformer_NER - INFO - Task will use CPU.
2023-11-23 20:52:26 - Transformer_NER - WARNING - set tokenizer as bert-base-uncased
2023-11-23 20:52:26 - Transformer_NER - WARNING - set config as bert-base-uncased
2023-11-23 20:52:26 - Transformer_NER - INFO - Training/evaluation parameters: {'model_type': 'bert', 'pretrained_model': 'bert-base-uncased', 'resume_from_model': None, 'config_name': 'bert-base-uncased', 'tokenizer_name': 'bert-base-uncased', 'data_dir': './merge', 'data_has_offset_information': True, 'new_model_dir': './new_bert_ner_model', 'save_model_core': True, 'predict_output_file': None, 'overwrite_model_dir': True, 'seed': 13, 'max_seq_length': 128, 'do_train': True, 'model_selection_scoring': 'strict-f_score-1', 'do_predict': False, 'use_crf': False, 'do_lower_case': True, 'train_batch_size': 8, 'eval_batch_size': 8, 'train_steps': 1000, 'learning_rate': 1e-05, 'min_lr': 1e-06, 'num_train_epochs': 20.0, 'gradient_accumulation_steps': 1, 'do_warmup': True, 'warmup_ratio': 0.1, 'weight_decay': 0.0, 'adam_epsilon': 1e-08, 'max_grad_norm': 1.0, 'max_num_checkpoints': 1, 'log_file': './log.txt', 'log_lvl': 'i', 'progress_bar': True, 'early_stop': 3, 'focal_loss': False, 'focal_loss_gamma': 2, 'use_biaffine': False, 'mlp_dim': 128, 'mlp_layers': 0, 'mlp_hidden_dim': 0, 'adversarial_training_method': None, 'fp16': False, 'logger': <Logger Transformer_NER (INFO)>, 'device': device(type='cpu'), 'num_labels': 4, 'label2idx': {'O': 3, 'X': 2, 'PAD': 0, 'CLS': 1}, 'idx2label': {3: 'O', 2: 'X', 0: 'PAD', 1: 'CLS'}}
2023-11-23 20:52:34 - Transformer_NER - INFO - New Model Config:
BertConfig {
  "architectures": [
    "BertForMaskedLM"
  ],
  "attention_probs_dropout_prob": 0.1,
  "classifier_dropout": null,
  "focal_loss_gamma": 2,
  "gradient_checkpointing": false,
  "hidden_act": "gelu",
  "hidden_dropout_prob": 0.1,
  "hidden_size": 768,
  "id2label": {
    "0": "LABEL_0",
    "1": "LABEL_1",
    "2": "LABEL_2",
    "3": "LABEL_3"
  },
  "initializer_range": 0.02,
  "intermediate_size": 3072,
  "label2id": {
    "LABEL_0": 0,
    "LABEL_1": 1,
    "LABEL_2": 2,
    "LABEL_3": 3
  },
  "label2idx": {
    "CLS": 1,
    "O": 3,
    "PAD": 0,
    "X": 2
  },
  "layer_norm_eps": 1e-12,
  "max_position_embeddings": 512,
  "mlp_dim": 128,
  "model_type": "bert",
  "num_attention_heads": 12,
  "num_hidden_layers": 12,
  "pad_token_id": 0,
  "position_embedding_type": "absolute",
  "transformers_version": "4.24.0",
  "type_vocab_size": 2,
  "use_cache": true,
  "use_crf": false,
  "use_focal_loss": false,
  "vocab_size": 30522
}

2023-11-23 20:52:45 - Transformer_NER - ERROR - Traceback (most recent call last):
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 386, in _make_request
    self._validate_conn(conn)
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 1042, in _validate_conn
    conn.connect()
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connection.py", line 414, in connect
    self.sock = ssl_wrap_socket(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\util\ssl_.py", line 449, in ssl_wrap_socket
    ssl_sock = _ssl_wrap_socket_impl(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\util\ssl_.py", line 493, in _ssl_wrap_socket_impl
    return ssl_context.wrap_socket(sock, server_hostname=server_hostname)
  File "C:\Users\HP\anaconda3\lib\ssl.py", line 513, in wrap_socket
    return self.sslsocket_class._create(
  File "C:\Users\HP\anaconda3\lib\ssl.py", line 1071, in _create
    self.do_handshake()
  File "C:\Users\HP\anaconda3\lib\ssl.py", line 1342, in do_handshake
    self._sslobj.do_handshake()
TimeoutError: _ssl.c:980: The handshake operation timed out

During handling of the above exception, another exception occurred:

Traceback (most recent call last):
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\adapters.py", line 489, in send
    resp = conn.urlopen(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 787, in urlopen
    retries = retries.increment(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\util\retry.py", line 550, in increment
    raise six.reraise(type(error), error, _stacktrace)
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\packages\six.py", line 770, in reraise
    raise value
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 703, in urlopen
    httplib_response = self._make_request(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 389, in _make_request
    self._raise_timeout(err=e, url=url, timeout_value=conn.timeout)
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 340, in _raise_timeout
    raise ReadTimeoutError(
urllib3.exceptions.ReadTimeoutError: HTTPSConnectionPool(host='cdn-lfs.huggingface.co', port=443): Read timed out. (read timeout=10.0)

During handling of the above exception, another exception occurred:

Traceback (most recent call last):
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\run_transformer_ner.py", line 169, in main
    run_task(global_args)
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\task.py", line 608, in run_task
    model = model_model.from_pretrained(args.pretrained_model, config=config)
  File "C:\Users\HP\anaconda3\lib\site-packages\transformers\modeling_utils.py", line 2091, in from_pretrained
    resolved_archive_file = cached_file(pretrained_model_name_or_path, filename, **cached_file_kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\transformers\utils\hub.py", line 409, in cached_file
    resolved_file = hf_hub_download(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\file_download.py", line 1226, in hf_hub_download
    http_get(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\file_download.py", line 470, in http_get
    r = _request_wrapper(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\file_download.py", line 433, in _request_wrapper
    return http_backoff(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\utils\_http.py", line 105, in http_backoff
    response = requests.request(method=method, url=url, **kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\api.py", line 59, in request
    return session.request(method=method, url=url, **kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\sessions.py", line 587, in request
    resp = self.send(prep, **send_kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\sessions.py", line 701, in send
    r = adapter.send(request, **kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\adapters.py", line 578, in send
    raise ReadTimeout(e, request=request)
requests.exceptions.ReadTimeout: HTTPSConnectionPool(host='cdn-lfs.huggingface.co', port=443): Read timed out. (read timeout=10.0)

2023-11-23 21:00:30 - Transformer_NER - INFO - Task will use CPU.
2023-11-23 21:00:30 - Transformer_NER - WARNING - set tokenizer as bert-base-uncased
2023-11-23 21:00:30 - Transformer_NER - WARNING - set config as bert-base-uncased
2023-11-23 21:00:31 - Transformer_NER - ERROR - Traceback (most recent call last):
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\run_transformer_ner.py", line 169, in main
    run_task(global_args)
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\task.py", line 557, in run_task
    labels, label2idx = ner_data_processor.get_labels(default=args.model_type)
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\data_utils.py", line 96, in get_labels
    _, train_labels = self._read_data(self.data_dir / "train.txt", task='train')
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\data_utils.py", line 125, in _read_data
    txt = f.read().strip()
  File "C:\Users\HP\anaconda3\lib\encodings\cp1252.py", line 23, in decode
    return codecs.charmap_decode(input,self.errors,decoding_table)[0]
UnicodeDecodeError: 'charmap' codec can't decode byte 0x90 in position 2336815: character maps to <undefined>

2023-11-23 21:05:36 - Transformer_NER - INFO - Task will use CPU.
2023-11-23 21:05:36 - Transformer_NER - WARNING - set tokenizer as bert-base-uncased
2023-11-23 21:05:36 - Transformer_NER - WARNING - set config as bert-base-uncased
2023-11-23 21:05:37 - Transformer_NER - INFO - Training/evaluation parameters: {'model_type': 'bert', 'pretrained_model': 'bert-base-uncased', 'resume_from_model': None, 'config_name': 'bert-base-uncased', 'tokenizer_name': 'bert-base-uncased', 'data_dir': './fbner', 'data_has_offset_information': True, 'new_model_dir': './new_bert_ner_model', 'save_model_core': True, 'predict_output_file': None, 'overwrite_model_dir': True, 'seed': 13, 'max_seq_length': 128, 'do_train': True, 'model_selection_scoring': 'strict-f_score-1', 'do_predict': False, 'use_crf': False, 'do_lower_case': True, 'train_batch_size': 8, 'eval_batch_size': 8, 'train_steps': 1000, 'learning_rate': 1e-05, 'min_lr': 1e-06, 'num_train_epochs': 20.0, 'gradient_accumulation_steps': 1, 'do_warmup': True, 'warmup_ratio': 0.1, 'weight_decay': 0.0, 'adam_epsilon': 1e-08, 'max_grad_norm': 1.0, 'max_num_checkpoints': 1, 'log_file': './log.txt', 'log_lvl': 'i', 'progress_bar': True, 'early_stop': 3, 'focal_loss': False, 'focal_loss_gamma': 2, 'use_biaffine': False, 'mlp_dim': 128, 'mlp_layers': 0, 'mlp_hidden_dim': 0, 'adversarial_training_method': None, 'fp16': False, 'logger': <Logger Transformer_NER (INFO)>, 'device': device(type='cpu'), 'num_labels': 34, 'label2idx': {'O': 3, 'X': 2, 'PAD': 0, 'CLS': 1, 'I-age': 4, 'B-age': 5, 'B-allergy_name': 6, 'I-allergy_name': 7, 'B-bmi': 8, 'I-bmi': 9, 'I-cancer': 10, 'B-cancer': 11, 'B-chronic_disease': 12, 'I-chronic_disease': 13, 'B-clinical_variable': 14, 'I-clinical_variable': 15, 'I-contraception_consent': 16, 'B-contraception_consent': 17, 'B-ethnicity': 18, 'I-ethnicity': 19, 'B-gender': 20, 'I-gender': 21, 'B-language_fluency': 22, 'I-language_fluency': 23, 'B-lower_bound': 24, 'I-lower_bound': 25, 'I-pregnancy': 26, 'B-pregnancy': 27, 'B-technology_access': 28, 'I-technology_access': 29, 'I-treatment': 30, 'B-treatment': 31, 'B-upper_bound': 32, 'I-upper_bound': 33}, 'idx2label': {3: 'O', 2: 'X', 0: 'PAD', 1: 'CLS', 4: 'I-age', 5: 'B-age', 6: 'B-allergy_name', 7: 'I-allergy_name', 8: 'B-bmi', 9: 'I-bmi', 10: 'I-cancer', 11: 'B-cancer', 12: 'B-chronic_disease', 13: 'I-chronic_disease', 14: 'B-clinical_variable', 15: 'I-clinical_variable', 16: 'I-contraception_consent', 17: 'B-contraception_consent', 18: 'B-ethnicity', 19: 'I-ethnicity', 20: 'B-gender', 21: 'I-gender', 22: 'B-language_fluency', 23: 'I-language_fluency', 24: 'B-lower_bound', 25: 'I-lower_bound', 26: 'I-pregnancy', 27: 'B-pregnancy', 28: 'B-technology_access', 29: 'I-technology_access', 30: 'I-treatment', 31: 'B-treatment', 32: 'B-upper_bound', 33: 'I-upper_bound'}}
2023-11-23 21:05:39 - Transformer_NER - INFO - New Model Config:
BertConfig {
  "architectures": [
    "BertForMaskedLM"
  ],
  "attention_probs_dropout_prob": 0.1,
  "classifier_dropout": null,
  "focal_loss_gamma": 2,
  "gradient_checkpointing": false,
  "hidden_act": "gelu",
  "hidden_dropout_prob": 0.1,
  "hidden_size": 768,
  "id2label": {
    "0": "LABEL_0",
    "1": "LABEL_1",
    "2": "LABEL_2",
    "3": "LABEL_3",
    "4": "LABEL_4",
    "5": "LABEL_5",
    "6": "LABEL_6",
    "7": "LABEL_7",
    "8": "LABEL_8",
    "9": "LABEL_9",
    "10": "LABEL_10",
    "11": "LABEL_11",
    "12": "LABEL_12",
    "13": "LABEL_13",
    "14": "LABEL_14",
    "15": "LABEL_15",
    "16": "LABEL_16",
    "17": "LABEL_17",
    "18": "LABEL_18",
    "19": "LABEL_19",
    "20": "LABEL_20",
    "21": "LABEL_21",
    "22": "LABEL_22",
    "23": "LABEL_23",
    "24": "LABEL_24",
    "25": "LABEL_25",
    "26": "LABEL_26",
    "27": "LABEL_27",
    "28": "LABEL_28",
    "29": "LABEL_29",
    "30": "LABEL_30",
    "31": "LABEL_31",
    "32": "LABEL_32",
    "33": "LABEL_33"
  },
  "initializer_range": 0.02,
  "intermediate_size": 3072,
  "label2id": {
    "LABEL_0": 0,
    "LABEL_1": 1,
    "LABEL_10": 10,
    "LABEL_11": 11,
    "LABEL_12": 12,
    "LABEL_13": 13,
    "LABEL_14": 14,
    "LABEL_15": 15,
    "LABEL_16": 16,
    "LABEL_17": 17,
    "LABEL_18": 18,
    "LABEL_19": 19,
    "LABEL_2": 2,
    "LABEL_20": 20,
    "LABEL_21": 21,
    "LABEL_22": 22,
    "LABEL_23": 23,
    "LABEL_24": 24,
    "LABEL_25": 25,
    "LABEL_26": 26,
    "LABEL_27": 27,
    "LABEL_28": 28,
    "LABEL_29": 29,
    "LABEL_3": 3,
    "LABEL_30": 30,
    "LABEL_31": 31,
    "LABEL_32": 32,
    "LABEL_33": 33,
    "LABEL_4": 4,
    "LABEL_5": 5,
    "LABEL_6": 6,
    "LABEL_7": 7,
    "LABEL_8": 8,
    "LABEL_9": 9
  },
  "label2idx": {
    "B-age": 5,
    "B-allergy_name": 6,
    "B-bmi": 8,
    "B-cancer": 11,
    "B-chronic_disease": 12,
    "B-clinical_variable": 14,
    "B-contraception_consent": 17,
    "B-ethnicity": 18,
    "B-gender": 20,
    "B-language_fluency": 22,
    "B-lower_bound": 24,
    "B-pregnancy": 27,
    "B-technology_access": 28,
    "B-treatment": 31,
    "B-upper_bound": 32,
    "CLS": 1,
    "I-age": 4,
    "I-allergy_name": 7,
    "I-bmi": 9,
    "I-cancer": 10,
    "I-chronic_disease": 13,
    "I-clinical_variable": 15,
    "I-contraception_consent": 16,
    "I-ethnicity": 19,
    "I-gender": 21,
    "I-language_fluency": 23,
    "I-lower_bound": 25,
    "I-pregnancy": 26,
    "I-technology_access": 29,
    "I-treatment": 30,
    "I-upper_bound": 33,
    "O": 3,
    "PAD": 0,
    "X": 2
  },
  "layer_norm_eps": 1e-12,
  "max_position_embeddings": 512,
  "mlp_dim": 128,
  "model_type": "bert",
  "num_attention_heads": 12,
  "num_hidden_layers": 12,
  "pad_token_id": 0,
  "position_embedding_type": "absolute",
  "transformers_version": "4.24.0",
  "type_vocab_size": 2,
  "use_cache": true,
  "use_crf": false,
  "use_focal_loss": false,
  "vocab_size": 30522
}

2023-11-23 21:05:50 - Transformer_NER - ERROR - Traceback (most recent call last):
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 386, in _make_request
    self._validate_conn(conn)
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 1042, in _validate_conn
    conn.connect()
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connection.py", line 414, in connect
    self.sock = ssl_wrap_socket(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\util\ssl_.py", line 449, in ssl_wrap_socket
    ssl_sock = _ssl_wrap_socket_impl(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\util\ssl_.py", line 493, in _ssl_wrap_socket_impl
    return ssl_context.wrap_socket(sock, server_hostname=server_hostname)
  File "C:\Users\HP\anaconda3\lib\ssl.py", line 513, in wrap_socket
    return self.sslsocket_class._create(
  File "C:\Users\HP\anaconda3\lib\ssl.py", line 1071, in _create
    self.do_handshake()
  File "C:\Users\HP\anaconda3\lib\ssl.py", line 1342, in do_handshake
    self._sslobj.do_handshake()
TimeoutError: _ssl.c:980: The handshake operation timed out

During handling of the above exception, another exception occurred:

Traceback (most recent call last):
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\adapters.py", line 489, in send
    resp = conn.urlopen(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 787, in urlopen
    retries = retries.increment(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\util\retry.py", line 550, in increment
    raise six.reraise(type(error), error, _stacktrace)
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\packages\six.py", line 770, in reraise
    raise value
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 703, in urlopen
    httplib_response = self._make_request(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 389, in _make_request
    self._raise_timeout(err=e, url=url, timeout_value=conn.timeout)
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 340, in _raise_timeout
    raise ReadTimeoutError(
urllib3.exceptions.ReadTimeoutError: HTTPSConnectionPool(host='cdn-lfs.huggingface.co', port=443): Read timed out. (read timeout=10.0)

During handling of the above exception, another exception occurred:

Traceback (most recent call last):
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\run_transformer_ner.py", line 169, in main
    run_task(global_args)
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\task.py", line 608, in run_task
    model = model_model.from_pretrained(args.pretrained_model, config=config)
  File "C:\Users\HP\anaconda3\lib\site-packages\transformers\modeling_utils.py", line 2091, in from_pretrained
    resolved_archive_file = cached_file(pretrained_model_name_or_path, filename, **cached_file_kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\transformers\utils\hub.py", line 409, in cached_file
    resolved_file = hf_hub_download(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\file_download.py", line 1226, in hf_hub_download
    http_get(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\file_download.py", line 470, in http_get
    r = _request_wrapper(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\file_download.py", line 433, in _request_wrapper
    return http_backoff(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\utils\_http.py", line 105, in http_backoff
    response = requests.request(method=method, url=url, **kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\api.py", line 59, in request
    return session.request(method=method, url=url, **kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\sessions.py", line 587, in request
    resp = self.send(prep, **send_kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\sessions.py", line 701, in send
    r = adapter.send(request, **kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\adapters.py", line 578, in send
    raise ReadTimeout(e, request=request)
requests.exceptions.ReadTimeout: HTTPSConnectionPool(host='cdn-lfs.huggingface.co', port=443): Read timed out. (read timeout=10.0)

2023-11-23 21:07:19 - Transformer_NER - INFO - Task will use CPU.
2023-11-23 21:07:19 - Transformer_NER - WARNING - set tokenizer as bert-base-uncased
2023-11-23 21:07:19 - Transformer_NER - WARNING - set config as bert-base-uncased
2023-11-23 21:07:20 - Transformer_NER - INFO - Training/evaluation parameters: {'model_type': 'bert', 'pretrained_model': 'bert-base-uncased', 'resume_from_model': None, 'config_name': 'bert-base-uncased', 'tokenizer_name': 'bert-base-uncased', 'data_dir': './fbner', 'data_has_offset_information': True, 'new_model_dir': './new_bert_ner_model', 'save_model_core': True, 'predict_output_file': None, 'overwrite_model_dir': True, 'seed': 13, 'max_seq_length': 128, 'do_train': True, 'model_selection_scoring': 'strict-f_score-1', 'do_predict': False, 'use_crf': False, 'do_lower_case': True, 'train_batch_size': 8, 'eval_batch_size': 8, 'train_steps': 1000, 'learning_rate': 1e-05, 'min_lr': 1e-06, 'num_train_epochs': 20.0, 'gradient_accumulation_steps': 1, 'do_warmup': True, 'warmup_ratio': 0.1, 'weight_decay': 0.0, 'adam_epsilon': 1e-08, 'max_grad_norm': 1.0, 'max_num_checkpoints': 1, 'log_file': './log.txt', 'log_lvl': 'i', 'progress_bar': True, 'early_stop': 3, 'focal_loss': False, 'focal_loss_gamma': 2, 'use_biaffine': False, 'mlp_dim': 128, 'mlp_layers': 0, 'mlp_hidden_dim': 0, 'adversarial_training_method': None, 'fp16': False, 'logger': <Logger Transformer_NER (INFO)>, 'device': device(type='cpu'), 'num_labels': 34, 'label2idx': {'O': 3, 'X': 2, 'PAD': 0, 'CLS': 1, 'I-age': 4, 'B-age': 5, 'B-allergy_name': 6, 'I-allergy_name': 7, 'B-bmi': 8, 'I-bmi': 9, 'I-cancer': 10, 'B-cancer': 11, 'I-chronic_disease': 12, 'B-chronic_disease': 13, 'I-clinical_variable': 14, 'B-clinical_variable': 15, 'B-contraception_consent': 16, 'I-contraception_consent': 17, 'B-ethnicity': 18, 'I-ethnicity': 19, 'I-gender': 20, 'B-gender': 21, 'B-language_fluency': 22, 'I-language_fluency': 23, 'B-lower_bound': 24, 'I-lower_bound': 25, 'B-pregnancy': 26, 'I-pregnancy': 27, 'B-technology_access': 28, 'I-technology_access': 29, 'B-treatment': 30, 'I-treatment': 31, 'B-upper_bound': 32, 'I-upper_bound': 33}, 'idx2label': {3: 'O', 2: 'X', 0: 'PAD', 1: 'CLS', 4: 'I-age', 5: 'B-age', 6: 'B-allergy_name', 7: 'I-allergy_name', 8: 'B-bmi', 9: 'I-bmi', 10: 'I-cancer', 11: 'B-cancer', 12: 'I-chronic_disease', 13: 'B-chronic_disease', 14: 'I-clinical_variable', 15: 'B-clinical_variable', 16: 'B-contraception_consent', 17: 'I-contraception_consent', 18: 'B-ethnicity', 19: 'I-ethnicity', 20: 'I-gender', 21: 'B-gender', 22: 'B-language_fluency', 23: 'I-language_fluency', 24: 'B-lower_bound', 25: 'I-lower_bound', 26: 'B-pregnancy', 27: 'I-pregnancy', 28: 'B-technology_access', 29: 'I-technology_access', 30: 'B-treatment', 31: 'I-treatment', 32: 'B-upper_bound', 33: 'I-upper_bound'}}
2023-11-23 21:07:22 - Transformer_NER - INFO - New Model Config:
BertConfig {
  "architectures": [
    "BertForMaskedLM"
  ],
  "attention_probs_dropout_prob": 0.1,
  "classifier_dropout": null,
  "focal_loss_gamma": 2,
  "gradient_checkpointing": false,
  "hidden_act": "gelu",
  "hidden_dropout_prob": 0.1,
  "hidden_size": 768,
  "id2label": {
    "0": "LABEL_0",
    "1": "LABEL_1",
    "2": "LABEL_2",
    "3": "LABEL_3",
    "4": "LABEL_4",
    "5": "LABEL_5",
    "6": "LABEL_6",
    "7": "LABEL_7",
    "8": "LABEL_8",
    "9": "LABEL_9",
    "10": "LABEL_10",
    "11": "LABEL_11",
    "12": "LABEL_12",
    "13": "LABEL_13",
    "14": "LABEL_14",
    "15": "LABEL_15",
    "16": "LABEL_16",
    "17": "LABEL_17",
    "18": "LABEL_18",
    "19": "LABEL_19",
    "20": "LABEL_20",
    "21": "LABEL_21",
    "22": "LABEL_22",
    "23": "LABEL_23",
    "24": "LABEL_24",
    "25": "LABEL_25",
    "26": "LABEL_26",
    "27": "LABEL_27",
    "28": "LABEL_28",
    "29": "LABEL_29",
    "30": "LABEL_30",
    "31": "LABEL_31",
    "32": "LABEL_32",
    "33": "LABEL_33"
  },
  "initializer_range": 0.02,
  "intermediate_size": 3072,
  "label2id": {
    "LABEL_0": 0,
    "LABEL_1": 1,
    "LABEL_10": 10,
    "LABEL_11": 11,
    "LABEL_12": 12,
    "LABEL_13": 13,
    "LABEL_14": 14,
    "LABEL_15": 15,
    "LABEL_16": 16,
    "LABEL_17": 17,
    "LABEL_18": 18,
    "LABEL_19": 19,
    "LABEL_2": 2,
    "LABEL_20": 20,
    "LABEL_21": 21,
    "LABEL_22": 22,
    "LABEL_23": 23,
    "LABEL_24": 24,
    "LABEL_25": 25,
    "LABEL_26": 26,
    "LABEL_27": 27,
    "LABEL_28": 28,
    "LABEL_29": 29,
    "LABEL_3": 3,
    "LABEL_30": 30,
    "LABEL_31": 31,
    "LABEL_32": 32,
    "LABEL_33": 33,
    "LABEL_4": 4,
    "LABEL_5": 5,
    "LABEL_6": 6,
    "LABEL_7": 7,
    "LABEL_8": 8,
    "LABEL_9": 9
  },
  "label2idx": {
    "B-age": 5,
    "B-allergy_name": 6,
    "B-bmi": 8,
    "B-cancer": 11,
    "B-chronic_disease": 13,
    "B-clinical_variable": 15,
    "B-contraception_consent": 16,
    "B-ethnicity": 18,
    "B-gender": 21,
    "B-language_fluency": 22,
    "B-lower_bound": 24,
    "B-pregnancy": 26,
    "B-technology_access": 28,
    "B-treatment": 30,
    "B-upper_bound": 32,
    "CLS": 1,
    "I-age": 4,
    "I-allergy_name": 7,
    "I-bmi": 9,
    "I-cancer": 10,
    "I-chronic_disease": 12,
    "I-clinical_variable": 14,
    "I-contraception_consent": 17,
    "I-ethnicity": 19,
    "I-gender": 20,
    "I-language_fluency": 23,
    "I-lower_bound": 25,
    "I-pregnancy": 27,
    "I-technology_access": 29,
    "I-treatment": 31,
    "I-upper_bound": 33,
    "O": 3,
    "PAD": 0,
    "X": 2
  },
  "layer_norm_eps": 1e-12,
  "max_position_embeddings": 512,
  "mlp_dim": 128,
  "model_type": "bert",
  "num_attention_heads": 12,
  "num_hidden_layers": 12,
  "pad_token_id": 0,
  "position_embedding_type": "absolute",
  "transformers_version": "4.24.0",
  "type_vocab_size": 2,
  "use_cache": true,
  "use_crf": false,
  "use_focal_loss": false,
  "vocab_size": 30522
}

2023-11-23 21:07:33 - Transformer_NER - ERROR - Traceback (most recent call last):
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 386, in _make_request
    self._validate_conn(conn)
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 1042, in _validate_conn
    conn.connect()
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connection.py", line 414, in connect
    self.sock = ssl_wrap_socket(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\util\ssl_.py", line 449, in ssl_wrap_socket
    ssl_sock = _ssl_wrap_socket_impl(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\util\ssl_.py", line 493, in _ssl_wrap_socket_impl
    return ssl_context.wrap_socket(sock, server_hostname=server_hostname)
  File "C:\Users\HP\anaconda3\lib\ssl.py", line 513, in wrap_socket
    return self.sslsocket_class._create(
  File "C:\Users\HP\anaconda3\lib\ssl.py", line 1071, in _create
    self.do_handshake()
  File "C:\Users\HP\anaconda3\lib\ssl.py", line 1342, in do_handshake
    self._sslobj.do_handshake()
TimeoutError: _ssl.c:980: The handshake operation timed out

During handling of the above exception, another exception occurred:

Traceback (most recent call last):
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\adapters.py", line 489, in send
    resp = conn.urlopen(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 787, in urlopen
    retries = retries.increment(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\util\retry.py", line 550, in increment
    raise six.reraise(type(error), error, _stacktrace)
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\packages\six.py", line 770, in reraise
    raise value
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 703, in urlopen
    httplib_response = self._make_request(
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 389, in _make_request
    self._raise_timeout(err=e, url=url, timeout_value=conn.timeout)
  File "C:\Users\HP\anaconda3\lib\site-packages\urllib3\connectionpool.py", line 340, in _raise_timeout
    raise ReadTimeoutError(
urllib3.exceptions.ReadTimeoutError: HTTPSConnectionPool(host='cdn-lfs.huggingface.co', port=443): Read timed out. (read timeout=10.0)

During handling of the above exception, another exception occurred:

Traceback (most recent call last):
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\run_transformer_ner.py", line 169, in main
    run_task(global_args)
  File "C:\Users\HP\Desktop\7th Sem\CSD361 Introduction to ML\Project\src\transformer_ner\task.py", line 608, in run_task
    model = model_model.from_pretrained(args.pretrained_model, config=config)
  File "C:\Users\HP\anaconda3\lib\site-packages\transformers\modeling_utils.py", line 2091, in from_pretrained
    resolved_archive_file = cached_file(pretrained_model_name_or_path, filename, **cached_file_kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\transformers\utils\hub.py", line 409, in cached_file
    resolved_file = hf_hub_download(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\file_download.py", line 1226, in hf_hub_download
    http_get(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\file_download.py", line 470, in http_get
    r = _request_wrapper(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\file_download.py", line 433, in _request_wrapper
    return http_backoff(
  File "C:\Users\HP\anaconda3\lib\site-packages\huggingface_hub\utils\_http.py", line 105, in http_backoff
    response = requests.request(method=method, url=url, **kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\api.py", line 59, in request
    return session.request(method=method, url=url, **kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\sessions.py", line 587, in request
    resp = self.send(prep, **send_kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\sessions.py", line 701, in send
    r = adapter.send(request, **kwargs)
  File "C:\Users\HP\anaconda3\lib\site-packages\requests\adapters.py", line 578, in send
    raise ReadTimeout(e, request=request)
requests.exceptions.ReadTimeout: HTTPSConnectionPool(host='cdn-lfs.huggingface.co', port=443): Read timed out. (read timeout=10.0)

2023-11-23 21:09:59 - Transformer_NER - INFO - Task will use CPU.
2023-11-23 21:09:59 - Transformer_NER - WARNING - set tokenizer as bert-base-uncased
2023-11-23 21:09:59 - Transformer_NER - WARNING - set config as bert-base-uncased
2023-11-23 21:10:00 - Transformer_NER - INFO - Training/evaluation parameters: {'model_type': 'bert', 'pretrained_model': 'bert-base-uncased', 'resume_from_model': None, 'config_name': 'bert-base-uncased', 'tokenizer_name': 'bert-base-uncased', 'data_dir': './fbner', 'data_has_offset_information': True, 'new_model_dir': './new_bert_ner_model', 'save_model_core': True, 'predict_output_file': None, 'overwrite_model_dir': True, 'seed': 13, 'max_seq_length': 128, 'do_train': True, 'model_selection_scoring': 'strict-f_score-1', 'do_predict': False, 'use_crf': False, 'do_lower_case': True, 'train_batch_size': 8, 'eval_batch_size': 8, 'train_steps': 1000, 'learning_rate': 1e-05, 'min_lr': 1e-06, 'num_train_epochs': 20.0, 'gradient_accumulation_steps': 1, 'do_warmup': True, 'warmup_ratio': 0.1, 'weight_decay': 0.0, 'adam_epsilon': 1e-08, 'max_grad_norm': 1.0, 'max_num_checkpoints': 1, 'log_file': './log.txt', 'log_lvl': 'i', 'progress_bar': True, 'early_stop': 3, 'focal_loss': False, 'focal_loss_gamma': 2, 'use_biaffine': False, 'mlp_dim': 128, 'mlp_layers': 0, 'mlp_hidden_dim': 0, 'adversarial_training_method': None, 'fp16': False, 'logger': <Logger Transformer_NER (INFO)>, 'device': device(type='cpu'), 'num_labels': 34, 'label2idx': {'O': 3, 'X': 2, 'PAD': 0, 'CLS': 1, 'B-age': 4, 'I-age': 5, 'B-allergy_name': 6, 'I-allergy_name': 7, 'B-bmi': 8, 'I-bmi': 9, 'B-cancer': 10, 'I-cancer': 11, 'I-chronic_disease': 12, 'B-chronic_disease': 13, 'I-clinical_variable': 14, 'B-clinical_variable': 15, 'B-contraception_consent': 16, 'I-contraception_consent': 17, 'B-ethnicity': 18, 'I-ethnicity': 19, 'I-gender': 20, 'B-gender': 21, 'I-language_fluency': 22, 'B-language_fluency': 23, 'I-lower_bound': 24, 'B-lower_bound': 25, 'B-pregnancy': 26, 'I-pregnancy': 27, 'I-technology_access': 28, 'B-technology_access': 29, 'I-treatment': 30, 'B-treatment': 31, 'I-upper_bound': 32, 'B-upper_bound': 33}, 'idx2label': {3: 'O', 2: 'X', 0: 'PAD', 1: 'CLS', 4: 'B-age', 5: 'I-age', 6: 'B-allergy_name', 7: 'I-allergy_name', 8: 'B-bmi', 9: 'I-bmi', 10: 'B-cancer', 11: 'I-cancer', 12: 'I-chronic_disease', 13: 'B-chronic_disease', 14: 'I-clinical_variable', 15: 'B-clinical_variable', 16: 'B-contraception_consent', 17: 'I-contraception_consent', 18: 'B-ethnicity', 19: 'I-ethnicity', 20: 'I-gender', 21: 'B-gender', 22: 'I-language_fluency', 23: 'B-language_fluency', 24: 'I-lower_bound', 25: 'B-lower_bound', 26: 'B-pregnancy', 27: 'I-pregnancy', 28: 'I-technology_access', 29: 'B-technology_access', 30: 'I-treatment', 31: 'B-treatment', 32: 'I-upper_bound', 33: 'B-upper_bound'}}
2023-11-23 21:10:02 - Transformer_NER - INFO - New Model Config:
BertConfig {
  "architectures": [
    "BertForMaskedLM"
  ],
  "attention_probs_dropout_prob": 0.1,
  "classifier_dropout": null,
  "focal_loss_gamma": 2,
  "gradient_checkpointing": false,
  "hidden_act": "gelu",
  "hidden_dropout_prob": 0.1,
  "hidden_size": 768,
  "id2label": {
    "0": "LABEL_0",
    "1": "LABEL_1",
    "2": "LABEL_2",
    "3": "LABEL_3",
    "4": "LABEL_4",
    "5": "LABEL_5",
    "6": "LABEL_6",
    "7": "LABEL_7",
    "8": "LABEL_8",
    "9": "LABEL_9",
    "10": "LABEL_10",
    "11": "LABEL_11",
    "12": "LABEL_12",
    "13": "LABEL_13",
    "14": "LABEL_14",
    "15": "LABEL_15",
    "16": "LABEL_16",
    "17": "LABEL_17",
    "18": "LABEL_18",
    "19": "LABEL_19",
    "20": "LABEL_20",
    "21": "LABEL_21",
    "22": "LABEL_22",
    "23": "LABEL_23",
    "24": "LABEL_24",
    "25": "LABEL_25",
    "26": "LABEL_26",
    "27": "LABEL_27",
    "28": "LABEL_28",
    "29": "LABEL_29",
    "30": "LABEL_30",
    "31": "LABEL_31",
    "32": "LABEL_32",
    "33": "LABEL_33"
  },
  "initializer_range": 0.02,
  "intermediate_size": 3072,
  "label2id": {
    "LABEL_0": 0,
    "LABEL_1": 1,
    "LABEL_10": 10,
    "LABEL_11": 11,
    "LABEL_12": 12,
    "LABEL_13": 13,
    "LABEL_14": 14,
    "LABEL_15": 15,
    "LABEL_16": 16,
    "LABEL_17": 17,
    "LABEL_18": 18,
    "LABEL_19": 19,
    "LABEL_2": 2,
    "LABEL_20": 20,
    "LABEL_21": 21,
    "LABEL_22": 22,
    "LABEL_23": 23,
    "LABEL_24": 24,
    "LABEL_25": 25,
    "LABEL_26": 26,
    "LABEL_27": 27,
    "LABEL_28": 28,
    "LABEL_29": 29,
    "LABEL_3": 3,
    "LABEL_30": 30,
    "LABEL_31": 31,
    "LABEL_32": 32,
    "LABEL_33": 33,
    "LABEL_4": 4,
    "LABEL_5": 5,
    "LABEL_6": 6,
    "LABEL_7": 7,
    "LABEL_8": 8,
    "LABEL_9": 9
  },
  "label2idx": {
    "B-age": 4,
    "B-allergy_name": 6,
    "B-bmi": 8,
    "B-cancer": 10,
    "B-chronic_disease": 13,
    "B-clinical_variable": 15,
    "B-contraception_consent": 16,
    "B-ethnicity": 18,
    "B-gender": 21,
    "B-language_fluency": 23,
    "B-lower_bound": 25,
    "B-pregnancy": 26,
    "B-technology_access": 29,
    "B-treatment": 31,
    "B-upper_bound": 33,
    "CLS": 1,
    "I-age": 5,
    "I-allergy_name": 7,
    "I-bmi": 9,
    "I-cancer": 11,
    "I-chronic_disease": 12,
    "I-clinical_variable": 14,
    "I-contraception_consent": 17,
    "I-ethnicity": 19,
    "I-gender": 20,
    "I-language_fluency": 22,
    "I-lower_bound": 24,
    "I-pregnancy": 27,
    "I-technology_access": 28,
    "I-treatment": 30,
    "I-upper_bound": 32,
    "O": 3,
    "PAD": 0,
    "X": 2
  },
  "layer_norm_eps": 1e-12,
  "max_position_embeddings": 512,
  "mlp_dim": 128,
  "model_type": "bert",
  "num_attention_heads": 12,
  "num_hidden_layers": 12,
  "pad_token_id": 0,
  "position_embedding_type": "absolute",
  "transformers_version": "4.24.0",
  "type_vocab_size": 2,
  "use_cache": true,
  "use_crf": false,
  "use_focal_loss": false,
  "vocab_size": 30522
}

2023-11-23 21:12:04 - Transformer_NER - INFO - 
************** Example ************
input tokens: ['[CLS]', 'eligible', 'to', 'undergo', 'ex', '##cision', '##al', 'surgery', 'such', 'as', 'pl', '##eur', '##ect', '##omy', '/', 'decor', '##tica', '##tion', '(', 'p', '/', 'dc', ')', 'or', 'any', 'other', 'me', '##so', '##the', '##lio', '##ma', 'surgery', '[SEP]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]']
input ids: [101, 7792, 2000, 13595, 4654, 28472, 2389, 5970, 2107, 2004, 20228, 11236, 22471, 16940, 1013, 25545, 22723, 3508, 1006, 1052, 1013, 5887, 1007, 2030, 2151, 2060, 2033, 6499, 10760, 12798, 2863, 5970, 102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
label: [1, 3, 3, 3, 31, 2, 2, 30, 3, 3, 31, 2, 2, 2, 30, 30, 2, 2, 30, 30, 30, 30, 30, 3, 3, 3, 31, 2, 2, 2, 2, 30, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
mask: [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
segment ids: [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
guards: [0, 1, 2, 3, 4, 4, 4, 5, 6, 7, 8, 8, 8, 8, 9, 10, 10, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 19, 19, 19, 19, 20, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
***********************************
            
2023-11-23 21:12:04 - Transformer_NER - INFO - 
************** Example ************
input tokens: ['[CLS]', 'his', '##to', '##logical', '##ly', 'confirmed', 'mali', '##gnant', 'pl', '##eur', '##al', 'me', '##so', '##the', '##lio', '##ma', 'that', 'is', 'not', 'meta', '##static', 'or', 'un', '##res', '##ect', '##able', '[SEP]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]']
input ids: [101, 2010, 3406, 9966, 2135, 4484, 16007, 27881, 20228, 11236, 2389, 2033, 6499, 10760, 12798, 2863, 2008, 2003, 2025, 18804, 16677, 2030, 4895, 6072, 22471, 3085, 102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
label: [1, 3, 2, 2, 2, 3, 3, 2, 10, 2, 2, 11, 2, 2, 2, 2, 3, 3, 3, 10, 2, 3, 3, 2, 2, 2, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
mask: [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
segment ids: [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
guards: [0, 1, 1, 1, 1, 2, 3, 3, 4, 4, 4, 5, 5, 5, 5, 5, 6, 7, 8, 9, 9, 10, 11, 11, 11, 11, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
***********************************
            
2023-11-23 21:12:04 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 136).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
This includes inflammatory bowel disease , ulcerative colitis , Crohn 's disease , systemic vasculitis , scleroderma , psoriasis , multiple sclerosis , hemolytic anemia , immune - mediated thrombocytopenia , rheumatoid arthritis , systemic lupus erythematosus , Sjogren 's syndrome , sarcoidosis , or other rheumatologic disease or any other medical condition or use of medication ( e.g. , corticosteroids ) which might make it difficult for the patient to complete the full course of treatments or to generate an immune response to vaccines

2023-11-23 21:12:05 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 129).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Advanced stage cutaneous T - cell lymphoma ( CTCL ) , specifically CTCL NOS , small / medium T - cell lymphoma ( SMTCL ) and mycosis fungoides ( MF ) stage IB , IIA , IIB , III and IV that have relapsed after at least one specific prior therapy ( e.g. interferon , photopheresis , denileukin difitox , bexarotene , etc ) ; anaplastic cutaneous large cell lymphoma ( ACLCL ) and lymphomatoid papulopsis

2023-11-23 21:12:05 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 153).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
All potential patients must undergo a tuberculosis ( TB ) test prior to study entry to rule out active or latent tuberculosis ( either purified protein derivative [ PPD ] or QuantiFERON - TB Gold , whichever is preferred and available at the institution ) ; patients with a history of TB ( even if treated ) , or evidence of active or latent TB , are excluded ; the diagnosis of active TB is defined per current guidelines ; patients with a positive TB test ( e.g. PPD or QuantiFERON - TB Gold ) will be excluded ; patients with history of Bacille - Calmette - Guerin ( BCG ) vaccination will be tested with QuantiFERON - TB Gold test in order to rule out exposure to TB

2023-11-23 21:12:05 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 157).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients must have relapsed ( recurrence after complete response or presented progression after partial response ) after last rituximab - containing therapy ( other previous treatment lines after rituximab are allowed ) . A previous regimen is defined as one of the following : at least 2 months of single - agent therapy ( less than 2 months of therapy is allowed for patients who responded to single - agent rituximab ) ; at least 2 consecutive cycles of polychemotherapy ; autologous transplant ; radioimmunotherapy . Previous exposure to PI3 K is acceptable ( except to copanlisib ) provided there is no resistance . Patients with prior intolerance to PI3 K inhibitors other than copanlisib are eligible

2023-11-23 21:12:07 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 144).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Pediatric Population ( patients < 18 years ): Creatinine within normal limits or calculated creatinine clearance greater than or equal to 90 ml / min/1.73 m2 as calculated by the Schwartz formula for estimated glomerular filtration rate ( GFR ) where GFR ( ml / min/1.73 m2 ) = k x Height ( cm)/serum creatinine ( mg / dl ) . k is a proportionality constant which varies with age and is a function of urinary creatinine excretion per unit of body size ; 0.45 up to 12 months of age ; 0.55 children and adolescent girls ; and 0.70 adolescent boys

2023-11-23 21:12:07 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 154).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
RB proficiency means that there is an intact RB pathway indicative of responsiveness to PD-0332991 . RB staining is scored on an absent ( no nuclear staining ) , weak ( nuclear staining less than observed in endothelial cells and stromal cells surrounding the tumor ) , positive ( nuclear staining at or above surrounding tissue ) ( 0 , 0.5 , 1 respectively ) . P16ink4a is a routine clinical stain that is scored using absent , weak , positive , strong ( 0,1,2,3 respectively ) . Tumors will be scored using [ p16]/[RB ] , where a score of less than 3 is required for inclusion . RB loss is expected to occur in less than 15 % of cases

2023-11-23 21:12:08 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Baseline lab values at the time of consent of : white blood cells ( K / uL ) > 14 or < 2 , hematocrit < 30 , platelets ( K / uL ) < 30,000 , non - pharmacologic INR > 1.7 , CA19 - 9 > 2X ULN(unit / ml ) , lipase ( U / L ) > 2 X the upper limit of normal , creatinine ( mg / dl ) > 3.0 unless stable on renal replacement therapy , ALT ( U / L ) > 500 , total bilirubin ( mg / dl ) > 2.5

2023-11-23 21:12:10 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 189).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The effects of onalespib and AT7519 M on the developing human fetus are unknown ; for this reason , women of childbearing potential and male patients with partners of childbearing potential must agree to use adequate contraception ( hormonal or barrier method of birth control or abstinence ) prior to study entry , for the duration of study participation , and for 2 months after completion of study ; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study , she should inform her treating physician immediately ; women of childbearing potential enrolling on study must have a negative pregnancy test within 72 hours of enrollment in order to be eligible ; because there is an unknown but potential risk to nursing infants secondary to treatment of the mother with onalespib and AT7519 M , breastfeeding should be discontinued while the mother is treated with onalespib and AT7519 M

2023-11-23 21:12:13 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 191).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Treatment , either current or within 28 days prior to Randomization , with any medications having a potential effect on alcohol consumption and related behaviors or mood . These include opioid antagonists ( e.g. , naltrexone , Vivitrol  , Selincro  ) , glutamate antagonists ( e.g. , acamprosate ) , anticonvulsants ( e.g. , topiramate , gabapentin ) , serotonin reuptake inhibitors ( e.g. , fluoxetine ) , serotonin antagonists ( e.g. , buspirone ) , other antidepressants ( e.g. , tricyclic antidepressants or monoamine oxidase inhibitors ) , dopamine antagonists ( e.g. , haloperidol ) , and disulfiram ( Antabuse  )

2023-11-23 21:12:14 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 129).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Refractory myositis patients are defined ( see Section 3.1.1 ) as having failed ( or considered intolerant to ) an adequate course of glucocorticoids or having failed glucocorticoids and at least one other immunosuppressive ( IS ) or immunomodulatory agent ( e.g. methotrexate , azathioprine , cyclosporine , tacrolimus , mycophenolate mofetil , cyclophosphamide , IVIg , anti - TNF agents , and rituximab )

2023-11-23 21:12:15 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 149).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Individuals currently taking alpha blockers ( terazosin , prazosin ) , hypnotics / benzodiazepines , atypical antipsychotics ( olanzapine , quetiapine , risperidone , clozapine ) , alpha-2 - agonists ( Clonidine , methyldopa , tizanidine , guanfacine ) , conivaptan , boceprevir , idelalisib , PDE-5 inhibitors or alpha-1 - antagonists , protease inhibitors ( treatment of HIV ) , oral antifungals , alfuzosin , pazopanib , silodosin , tadalafil , or tamulosin

2023-11-23 21:12:15 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 158).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
MRI exclusions : Claustrophobia ; tattoos above the shoulders after evaluation by MRI technician ; permanent eyeliner or permanent artificial eyebrows ; cardiac pacemaker ; metal fragments in eye , skin , or body , including shrapnel ; heart valve replacement ; brain clips ; venous umbrella ; being a sheet - metal worker or welder ; lifetime history of aneurysm surgery ; intracranial bypass , renal , or aortic clips ; prosthetic devices such as middle ear , eye , joint , or penile implants ; joint replacements ; non - removable hearing aid , neurostimulator , or insulin pump ; shunts / stents ; metal mesh / coil implants ; metal plate / pin / screws / wires ; or any other metal implants

2023-11-23 21:12:15 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 136).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Meet criteria for the following psychiatric and/or substance use disorders as assessed by the MINI International Neuropsychiatric Interview ( MINI ): items C ( current manic or hypomanic episode only ) , I ( alcohol abuse - Alcohol Addendum - past 6 months only ; current alcohol dependence ) , J ( substance abuse - Substance Abuse Addendum - past 6 months only ; current substance dependence ) , K ( current / lifetime psychotic disorder or current / lifetime mood disorder with psychotic features ) ; individuals who meet criteria for non - exclusionary psychiatric disorders that are considered clinically unstable and/or unsuitable to participate as determined by the principal investigator and/or study physician

2023-11-23 21:12:16 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 225).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The effects of the drugs used in this trial on the developing human fetus are unknown ; however , cabozantinib was embryolethal in rats at exposures below the 140 mg dose in the label , with increased incidences of skeletal variations in rats and visceral variations and malformations in rabbits ; for this reason and because tyrosine kinase inhibitors agents as well as other therapeutic agents used in this trial are known to be teratogenic , women of child - bearing potential and men must agree to use adequate contraception , as defined below , prior to study entry and for the duration of study participation ; should a woman become pregnant or suspect she is pregnant while she is participating in this study , she should inform her treating physician immediately ; men treated or enrolled on this protocol must also agree to use adequate contraception prior to the study , for the duration of study participation , and 7 months after completion of all study medications ; women treated or enrolled on this protocol must also agree to use adequate contraception prior to the study , for the duration of study participation , and for 5 months after completion of all study medications

2023-11-23 21:12:16 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 194).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Women of child bearing potential and male patients who are not surgically sterile must be willing to practice contraceptive methods for the duration of the study and for 30 - days following the last dose of study medication . Female patients must be postmenopausal ( greater than 12 months from onset of menopause ) or surgically sterile ( have undergone bilateral oophorectomy or hysterectomy ) . Women of child bearing potential and women < 12 months since onset of menopause must agree to use an acceptable contraception method . If employing contraception , 2 of the following precautions must be used : vasectomy of partner , tubal ligation , vaginal diaphragm , intrauterine device , oral contraceptives ( same oral contraceptive for a minimum of 3 months prior to screening ) , birth control injections , birth control implant , condom and spermicidal ( gel / foam / cream / vaginal suppository )

2023-11-23 21:12:18 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 239).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients at risk for endovascular infection ( previously documented rheumatic heart disease , congenital valve disease , surgically repaired congenital heart disease , unrepaired cyanotic congenital heart disease , any intracardiac repair with prosthetic material [ mechanical or bio - prosthetic cardiac valves ] , previous or current endocarditis , permanent endovascular devices ( e.g. , endovascular grafts [ e.g. , aortic aneurysm repair , stents involving large arteries such as aorta , femorals and carotids ] , inferior vena cava filters , dialysis vascular grafts ) , tunnelled ( not short - term ) hemodialysis catheters , pacemakers or defibrillators . Patients with temporary central venous catheters , central venous dialysis catheters or peripherally inserted central catheters ( PICCs ) are not excluded and patients with coronary artery stents , coronary artery bypass grafts ( CABG ) or neurovascular coils are not excluded ; patients with mitral valve prolapse or bicuspid aortic valve

2023-11-23 21:12:18 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 276).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients must have relapsed after high - dose therapy and autologous transplantation or be ineligible for high - dose therapy and autologous transplantation ; patients that have failed autologous transplantation are those with persistent disease > 30 days after transplant ; those ineligible for autologous transplant include those with chemoresistant disease ( i.e. , patients who have not achieved a partial response or better with their most recent chemotherapy regimen ) , are expected to have a poor outcome from autologous transplant ( e.g. , DLBCL relapsing within one year of rituximab , cyclophosphamide , doxorubicin hydrochloride , vincristine sulfate , prednisone [ R - CHOP]-like chemotherapy , double hit lymphoma , v - myc myelocytomatosis viral oncogene homolog ( avian ) positive [ MYC+ ] lymphoma , persistent positron emission tomography [ PET ] positivity after chemotherapy ) , are unable to collect sufficient or tumor - free autologous stem cells per Seattle Cancer Care Alliance ( SCCA ) standard practice , are unable to tolerate the high - dose autologous conditioning regimens , or who refuse a high - dose autologous transplant regimen

2023-11-23 21:12:18 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 135).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
3 of 5 criteria : ( i ) Elevated erythrocyte sedimentation rate ( ESR ) ( > 30mm / jr ) and c - reactive protein ( CRP ) ( > 10mg / L ) ( ii ) Elevated synovial leukocyte count ( > 3000 cells/L ) or change of + + on leukocyte esterase strip ( iii ) Elevated synovial neutrophil percentage ( > 80 % ) ( iv ) One positive culture ( v ) Positive histological analysis of periprosthetic tissue ( > 5 neutrophils per high power field in 5 high power fields x400 )

2023-11-23 21:12:22 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 127).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Prior open surgical or interventional procedure within 30 days of the anticipated date of the fenestrated - branched procedure , with the exception of planned staged procedures to provide access for repair ( e.g. staged iliac conduit , cervical debranching , elephant trunk repair ) , to facilitate the procedure by allowing open revascularization of a target artery not amenable to revascularization with the investigational device , such as an internal iliac artery , subclavian artery or visceral artery with early bifurcation , tortuosity or occlusive disease preventing successful placement of alignment side stents

2023-11-23 21:12:22 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 151).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Food or drugs that are known to be CYP3A4 inhibitors ( e.g. grapefruit juice , verapamil , ketoconazole , miconazole , itraconazole , erythromycin , clarithromycin , telithromycin , indinavir , ritonavir , nelfinavir , atazanavir , amprenavir , nefazodone , diltiazem , and delavirdine ) or inducers ( i.e. dexamethasone , glucocorticoids , progesterone , rifampin , phenobarbital , St. John 's wort )

2023-11-23 21:12:23 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 151).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
antivirals ( except for treatment of HSV with agents without CNS activity , e.g. acyclovir , ganciclovir , famciclovir , valacyclovir ) ; anxiolytics ; cough / cold preparations ( dextromethorphan preparations , pseudoephedrine ) ; hormones ( exceptions : thyroid hormone replacement , oral contraceptives , and estrogen replacement therapy ) ; insulin ; lithium ; muscle relaxants ; psychotropic drugs not otherwise specified ( nos ) including herbal products ( no drugs with psychomotor effects or with anxiolytics , stimulant , antipsychotic , or sedative properties ) ; sedatives / hypnotics

2023-11-23 21:12:23 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 147).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Strong CYP3A4 inhibitors : ( Patients must discontinue drug 7 days prior to starting ruxolitinib ) , including but not limited to boceprevir , clarithromycin , conivaptan , indinavir , itraconazole , ketoconazole , lopinavir , mibefradil , nefazodone , nelfinavir , posaconazole , ritonavir , saquinavir , telaprevir , telithromycin , or voriconazole . In addition , patients will be instructed to avoid grapefruit or grapefruit juice , starfruit , or seville oranges

2023-11-23 21:12:25 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 178).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
On scheduled strong or moderate CYP3A4 inhibitors ( boceprevir , clarithromycin , conivaptan , indinavir , itraconazole , ketoconazole , lopinavir / ritonavir , mibefradil , nefazodone , nelfinavir , posaconazole , ritonavir , saquinavir , telaprevir , telithromycin , voriconazole ; amprenavir , aprepitant , atazanavir , ciprofloxacin , darunavir / ritonavir , diltiazem , erythromycin , fluconazole , fosamprenavir , grapefruit juice , imatinib , verapamil ) within one week of study enrollment

2023-11-23 21:12:28 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 129).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients with symptomatic brain metastases should be excluded from this clinical trial because of their poor prognosis and because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events . However , patients who have had treatment for their brain metastases and whose brain metastatic disease status has remained stable for at least 1 week after the end of brain radiation may be enrolled to undergo molecular profiling at the discretion of the principal investigator . In addition , brain metastatic disease should be stable for at least 4 weeks , before the patients can be enrolled in any of the experimental treatment arms

2023-11-23 21:12:28 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 139).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The eligibility of patients taking medications that are potent inducers or inhibitors of that enzyme will be determined following a review of their case by the Principal Investigator . ( A list of potent CYP3A4 inducers or inhibitors can be found in Appendix F ) . Every effort should be made to switch patients taking such agents or substances to other medications before they begin treatment with one of the experimental drug included in this protocol , particularly patients with gliomas or brain metastases who are taking enzyme - inducing anticonvulsant agents . A comprehensive list of medications and substances known or with the potential to alter the pharmacokinetics of sunitinib through CYP3A4

2023-11-23 21:12:29 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 187).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The participating parent or child will not have had a concussion in the past three months ; will not have any significant developmental delays or intellectual disabilities ; will not be receiving treatment for a DSM-5 disorder that interferes with treatment delivered as part of the intervention ; will not have a physical disability or diagnosis that prevents performance of physical activity at a level equivalent to a brisk walk or that places severe restriction on diet ; will not be on a medication regimen that affects weight ; will not have a medical condition that alters nutritional status , intestinal absorption , or affects weight ; will not have undergone weight loss surgery ; and will not be participating in an alternate weight control program . Families in which either the participating child or parent is actively involved in other weight - loss treatment , is using weight - affecting medications , or has an impairing psychiatric or medical condition that would hinder participation in the study will be excluded as identified by the screening assessments

2023-11-23 21:12:29 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 170).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Impaired cardiac function or clinically significant cardiac diseases , including any of the following : history or presence of ventricular tachyarrhythmia ; presence of unstable atrial fibrillation ( ventricular response > 100 beats per minute [ bpm ] ) ; patients with stable atrial fibrillation are eligible , provided they do not meet any of the other cardiac exclusion criteria ; clinically significant resting bradycardia ( < 50 bpm ) ; angina pectoris or acute myocardial infarction = < 3 months prior to starting study drug ; other clinically significant heart disease ( e.g. , symptomatic congestive heart failure ; uncontrolled arrhythmia or hypertension ; history of labile hypertension or poor compliance with an antihypertensive regimen )

2023-11-23 21:12:29 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 134).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Subjects with evidence of severe or uncontrolled systemic disease , or any concurrent condition , which could compromise participation in the study , including , but not limited to , active or uncontrolled infection , immune deficiencies , Hepatitis B , Hepatitis C , uncontrolled diabetes , uncontrolled hypertension , symptomatic congestive heart failure , unstable angina pectoris , myocardial infarction within the past 6 months , uncontrolled cardiac arrhythmia , stroke / cerebrovascular accident within the past 6 months , or psychiatric illness / social situations which would jeopardize compliance with the protocol

2023-11-23 21:12:31 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 197).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Elective , open unilateral inguinal herniorrhaphy using Lichtenstein ( tension free with mesh ) hernia repair technique Agree to take only the prescribed oral analgesic medication ( oxycodone / acetaminophen ) , plus or minus ibuprofen , for the initial fourteen - day post - operative period , with allowed exception of any currently prescribed opioid ( codeine , hydrocodone , hydromorphone , morphine , methadone , oxymorphone , transdermal fentanyl ) , which can be continued . Agree to honestly complete a depression screening questionnaire , illicit drug use personal history and questionnaire , and physical activity assessment questionnaire , with the knowledge that if the patient is an active duty member , this information could result in a referral to medical or command authorities for potential Uniform Code of Military Justice ( UCMJ ) violations or concerns for subject health and fitness for duty

2023-11-23 21:12:33 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 134).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The investigators chose an upper eGFR limit slightly higher than the Kidney Disease Outcomes Quality Initiative ( KDOQI ) definition of moderately reduced glomerular filtration rate ( GFR ) to be more inclusive of patients with mild reduction in GFR but significant proteinuria . The lower eGFR limit was set to exclude patients with advanced CKD , where the potential effects of dietary sodium reduction on proteinuria may not be apparent or greatly alter CKD progression . The eGFR to define eligibility will be calculated using calibrated serum creatinine values and the Chronic Kidney Disease Epidemiology Collaboration ( CKD - EPI ) estimating equation

2023-11-23 21:12:33 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Have metal that would make an MRI scan unsafe such as : cardiac pacemaker , insulin infusion pump , implanted drug infusion devise , cochlear or ear implant , transdermal medication patch ( nitroglycerine ) , any metallic implants or objects , body piercing that can not be removed , bone or joint pin , screw , nail , plate , wire sutures or surgical staples , shunts , cerebral aneurysms clips , shrapnel or other metal embedded ( such as from war wounds or accidents or previous work in metal fields or machines that may have left any metallic fragments in or near your eyes )

2023-11-23 21:12:34 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Have a history of any autoimmune disease : inflammatory bowel disease , ( including ulcerative colitis and Crohn 's Disease ) , rheumatoid arthritis , systemic progressive sclerosis ( scleroderma ) , systemic lupus erythmatosus ( SLE ) autoimmune vasculitis ( e.g. , Wegener 's Granulomatosis ) , CNS or motor neuropathy considered to be of autoimmune origin ( e.g. , Guillian - Barre Syndrome , Myasthenia Gravis , Multiple Sclerosis )

2023-11-23 21:12:35 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 223).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients who have any severe and/or uncontrolled medical conditions such as : a. serious uncontrolled cardiac arrhythmia , or any other clinically significant cardiac disease b. active ( acute or chronic ) or uncontrolled severe infection , liver disease such as cirrhosis , decompensated liver disease , and active and chronic hepatitis ( i.e. quantifiable hepatitis B virus [ HBV]-deoxyribonucleic acid [ DNA ] and/or positive surface antigen of the hepatitis B virus [ HBsAg ] , quantifiable hepatitis C virus [ HCV]-ribonucleic acid [ RNA ] ) , c. known severely impaired lung function ( spirometry and Diffusing capacity of the lungs for carbon monoxide [ DLCO ] 50 % or less of normal and oxygen ( O2 ) saturation 88 % or less at rest on room air ) , d. active , bleeding diathesis ; e. Moderate or severe hepatic impairment ( Child - Pugh B or C )

2023-11-23 21:12:37 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 160).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
patients with progressive CLL following standard therapy who meet European Bone Marrow Transplant ( EBMT ) consensus guidelines of indications for allogeneic stem cell transplantation ; this includes patients with ( 1 ) lack of response or early relapse within 1 year of receiving a purine analog - containing treatment regimen , ( 2 ) disease relapse within 2 years of receiving a purine analog combination therapy or after other therapies such as autologous stem cell transplantation , and ( 3 ) CLL associated with tumor protein ( p)53 mutations or deletions and/or deletion ( del ) ( 17p ) requiring therapy ; patients must have chemosensitive disease with at least a partial response ( PR ) or stable disease ( SD ) with last treatment regimen

2023-11-23 21:12:39 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 168).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Has clinical response or stable disease for minimum of two months ( three cycles of every three week chemotherapy or 8 weeks of weekly regimen , etc . ) after receiving any prior chemotherapy for metastatic / recurrent disease ; a minimum of two cycles ( 6 - 8 weeks ) of chemotherapy is required to determine clinical response ; per Response Evaluation Criteria in Solid Tumors ( RECIST ) criteria 1.1 , clinical response for measurable disease is defined as complete response ( CR ) or partial response ( PR ) ; for non - measurable disease only ( i.e. bone metastasis , ascites , pleural effusion , and pathological lymph nodes > = 10 to < 15 mm short axis ) is defined as persistence of one or more non - target lesion(s ) and no increase in overall tumor burden

2023-11-23 21:12:39 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 139).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Has histological confirmation of HER2 normal breast carcinoma with a clinical diagnosis of IBC based on presence of inflammatory changes in the involved breast , including diffuse erythema and edema ( peau d'orange ) , with or without an underlying palpable mass involving the majority of the skin of the breast ; pathological evidence of dermal lymphatic invasion should be noted but is not required for diagnosis of inflammatory breast cancer regardless estrogen receptor ( ER)/progesterone receptor ( PR ) status ; OR has histological confirmation of triple negative breast carcinoma ( HER2 normal , ER / PR < 10 % ) without clinical diagnosis of IBC

2023-11-23 21:12:39 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 164).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
History of autoimmune disease , including but not limited to myasthenia gravis , myositis , autoimmune hepatitis , systemic lupus erythematosus , rheumatoid arthritis , inflammatory bowel disease , vascular thrombosis associated with antiphospholipid syndrome , Wegener 's granulomatosis , Sjgren 's syndrome , Guillain - Barr syndrome , multiple sclerosis , vasculitis , or glomerulonephritis . NOTE : patients with Grave 's disease and/or psoriasis not requiring systemic therapy within the last two years from randomization and patients with hypothyroidism ( e.g. following Hashimoto syndrome ) stable on hormone replacement are not excluded

2023-11-23 21:12:41 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 160).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients who have undergone systemic treatment , within 14 days prior to registration , with strong inhibitors of cytochrome P450 superfamily ( CYP)1A2 ( fluvoxamine , enoxacin , ciprofloxacin ) , strong inhibitors of CYP3A ( clarithromycin , telithromycin , itraconazole , voriconazole , ketoconazole , nefazodone , posaconazole ) or strong CYP3A inducers ( rifampin , rifapentine , rifabutin , carbamazepine , phenytoin , phenobarbital ) , or use of Ginkgo biloba or St. John 's wort

2023-11-23 21:12:41 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 143).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Have had known active central nervous system ( CNS ) metastases and/or carcinomatous meningitis ; subjects with previously treated brain metastases may participate provided they are stable ( without evidence of progression by imaging for at least four weeks prior to the first dose of trial treatment and any neurologic symptoms have returned to baseline ) , have no evidence of new or enlarging brain metastases , and are not using steroids for CNS involvement for at least one week prior to trial treatment ; patients with primary brain tumors are not eligible ; however , as patients are completing abiraterone therapy , they will be allowed to continue up to 10 mg / day of prednisone

2023-11-23 21:12:44 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 197).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
major depressive disorder , persistent depressive disorder , panic disorder , agoraphobia , social anxiety disorder , specific phobia , generalized anxiety disorder , obsessive - compulsive disorder , trichotillomania , excoriation disorder , hoarding disorder , body dysmorphic disorder , other specified , or unspecified obsessive - compulsive disorder , posttraumatic stress disorder , acute stress disorder , adjustment disorders , somatic symptom disorder , conversion disorder , anorexia nervosa , bulimia nervosa , binge - eating disorder , borderline personality disorder , narcissistic personality disorder , histrionic personality disorder , antisocial personality disorder , paranoid personality disorder , schizoid personality disorder , schizotypal personality disorder , avoidant personality disorder , dependent personality disorder , obsessive - compulsive personality disorder , personality disorder unspecified , depressive disorder unspecified , anxiety disorder unspecified

2023-11-23 21:12:45 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 163).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Barrier methods of contraception : Condom or Occlusive cap ( diaphragm or cervical / vault caps ) with spermicidal foam / gel / film / cream / vaginal suppository Women are considered post - menopausal and not of child bearing potential if they have had 12 months of natural ( spontaneous ) amenorrhea with an appropriate clinical profile ( e.g. age appropriate , history of vasomotor symptoms ) or have had surgical bilateral oophorectomy ( with or without hysterectomy ) or tubal ligation at least six weeks prior to enrolling . In the case of oophorectomy alone , only when the reproductive status of the woman has been confirmed by follow up hormone level assessment is she considered not of child bearing potential

2023-11-23 21:12:47 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 152).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Prior surgical or interventional procedure within 30 days of the anticipated date of the fenestrated procedure , with the exception of planned staged procedures to provide access for repair ( e.g. staged iliac conduit , thoracic endovascular aortic aneurysm repair for proximal aneurysms ) , to facilitate the procedure by allowing open reparation of a target artery not amenable to revascularization with the investigational device , such us an internal iliac artery , subclavian artery or visceral artery with early bifurcation , tortuosity or occlusive disease preventing successful placement and alignment side stents , or to treat proximal aortic aneurysms

2023-11-23 21:12:48 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 158).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Absolute Neutrophil Count ( ANC ) > /= 1,500 / microliter ; Platelets > /= 100,000 / microliter ; Hemoglobin ( Hgb ) > /= 9 g / dL ; Creatinine < /= 1.5 X upper limit of normal ( ULN ) ; Prothrombin Time ( PT ) , Partial Thromboplastin Time(PTT ) < /= 1.5 X ULN ; Total bilirubin < /= 1.5X ULN ; Alanine Transaminase ( ALT ) and Aspartate Aminotransferase ( AST ) < 1.5 X ULN ( < 5 X ULN if patient has liver metastasis )

2023-11-23 21:12:50 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 134).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Unstable cardiovascular function : symptomatic ischemia ( chest pain of cardiac origin ) , or uncontrolled clinically significant conduction abnormalities ( e.g. ventricular tachycardia on antiarrhythmics are excluded and 1st degree atrioventricular [ AV ] block or asymptomatic left anterior fascicular block [ LAFB]/right bundle branch block [ RBBB ] will not be excluded ) , or congestive heart failure ( CHF ) of New York Heart Association ( NYHA ) class > = 3 , or myocardial infarction ( MI ) within 3 months of consent date

2023-11-23 21:12:50 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 128).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patient has uncontrolled intercurrent illness including , but not limited to , symptomatic congestive heart failure , unstable angina pectoris , myocardial infarction within six months of protocol initiation , cardiac arrhythmia within six months of protocol initiation ; known inadequately controlled hypertension ; clinically significant pulmonary disease including dyspnea at rest , or patients requiring supplemental oxygen , or poor pulmonary reserve ; proteinuria or clinically significant renal function impairment ( baseline serum creatinine > 2 mg / dL ) ; or psychiatric illness / social situations that would limit compliance with study requirements

2023-11-23 21:12:50 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 137).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Trametinib can cause fetal harm when administered to a pregnant woman ; women of child - bearing potential and men must agree to use adequate contraception ( hormonal or barrier method of birth control ; abstinence ) prior to study entry , during the study participation , and for four months after the last dose of the drug ; women of child - bearing potential must have a negative serum pregnancy test within 14 days prior to registration and agree to use effective contraception throughout the treatment period and for 4 months after the last dose of study treatment ; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study , she should inform her treating physician immediately

2023-11-23 21:12:51 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
atients with fulminant liver failure , cirrhosis with evidence of portal hypertension or bridging fibrosis , alcoholic hepatitis , esophageal varices , a history of bleeding esophageal varices , hepatic encephalopathy , or correctable hepatic synthetic dysfunction evidenced by prolongation of the prothrombin time , ascites related to portal hypertension , bacterial or fungal abscess , biliary obstruction , chronic viral hepatitis with total serum bilirubin > 3 mg / dL , and symptomatic biliary disease will be excluded

2023-11-23 21:12:53 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 215).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
High risk for ovarian cancer due to familial predisposition as defined by the following : a. Known mutation in BRCA1 of BRCA2 . b. Two 1st or 2nd degree relatives of same lineage who have : two ovarian cancers ; one ovarian cancer & one pre - menopausal breast cancer ; two pre - menopausal breast cancers ; one pre - menopausal & one post - menopausal breast cancer . ( These conditions can also be met using the patient and one 1st or 2nd degree female relative . ) c. Ashkenazi Jewish descent with one 1st degree or two 2nd degree relatives with pre - menopausal breast or ovarian cancer or participant has had pre - menopausal breast cancer . d. 1st or 2nd degree male relative with breast cancer diagnosed at any age . ( First degree relative defined as children , siblings and parents . Second degree relative defined as half - siblings , aunts , uncles , nieces , nephews , grandparents , and grandchildren . )

2023-11-23 21:12:54 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 143).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
use of any of anti - retrovirals ( delavirdine ) or protease inhibitors ( ritonavir , indinavir , lopinavir / ritonavir , saquinavir , nelfinavir ) is permitted ; specifically , ritonavir and cobicistat is permitted for participants considered for the CYP3A4 - inhibitor based ART regimen arm ( Stratum A ) of the trial ; because the lists of CYP3A4 inhibitors are constantly changing , it is important to regularly consult a frequently - updated list ; medical reference texts such as the physicians ' desk reference may also provide this information ; as part of the enrollment / informed consent procedures

2023-11-23 21:12:54 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 128).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Alanine aminotransferase ( ALT ) ( serum glutamate pyruvate transaminase [ SGPT ] ) and aspartate aminotransferase ( AST ) ( serum glutamic oxaloacetic transaminase [ SGOT ] ) equal to or less than 2.5 x upper limit of normal ( ULN ) , or equal to or less than 4 x ULN ( if upon judgment of the treating physician , it is believed to be due to extramedullary hematopoiesis [ EMH ] related to myelofibrosis [ MF ] )

2023-11-23 21:12:54 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
This includes , but is not limited to : acute myeloid leukemia ( AML ) , acute lymphoblastic leukemia ( ALL ) , chronic myelogenous leukemia ( CML ) , chronic lymphocytic leukemia ( CLL ) , non - Hodgkin lymphoma ( NHL ) , Hodgkin lymphoma , multiple myeloma ( MM ) , myelodysplastic syndrome ( MDS ) , AL amyloidosis , diamond blackfan anemia , myelofibrosis or other myeloproliferative disease , sickle cell anemia , and thalassemia

2023-11-23 21:12:55 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 127).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Subjects with non - malignant pleural effusion identified on CT scan are eligible provided the effusion is not known or demonstrated to be an exudative effusion . If a pleural effusion is present , the following criteria must be met to exclude malignant involvement : A pleuracentesis is required if pleural fluid is present and visible on both CT scan and chest x - ray . Pleural fluid cytology must be negative for malignancy . Effusions that are minimal and too small for pleuracentesis as determined by the investigator will be eligible for enrollment

2023-11-23 21:12:56 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 164).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Eligible patients in the dose escalation phases of the trial must agree to biopsies of normal skin , unless they undergo optional tumor biopsies ; the mandatory biopsy requirement can be waived at the discretion of principal investigator in the event of any medical contraindication ( e.g. lidocaine allergy ) ; patients enrolled to the expanded cohorts must agree to tumor sampling ; patients on anticoagulation must be able to hold warfarin or low molecular weight heparin for a sufficient amount of time to make skin and tumor biopsies safe to perform ; PT / INR and PTT should be = < 1.5 times the institutional upper limit of normal prior to performance of skin or tumor biopsies , with values re - checked after the eligibility screen as medically indicated

2023-11-23 21:12:56 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 138).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients must not receive any other anti - cancer therapy ( cytotoxic , biologic , radiation , or hormonal other than for replacement ) while on this study except for medications that are prescribed for supportive care but may potentially have an anti - cancer effect ( i.e. megestrol acetate , bisphosphonates ) ; in addition , men receiving treatment for prostate cancer will be maintained at castrate levels of testosterone by continuation of luteinizing - releasing hormone agonists ; palliative radiation therapy ( XRT ) can be administered on study after documented discussion with the principal investigator ; for patients in expansion cohorts , this must not involve target lesions

2023-11-23 21:12:57 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 128).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Clinically significant cardiovascular disease that will be assessed on a case - by - case basis . Clinically significant cardiovascular disease usually includes one or more of the following : cardiac surgery or myocardial infarction within the last 4 weeks ; unstable angina ; acute decompensated congestive heart failure or class IV heart failure ; current significant cardiac arrhythmia or conduction disturbance , particularly those resulting in ventricular fibrillation , or causing syncope or near syncope ; uncontrolled high blood pressure ; QTc greater than 450msec ( by history for subjects with cardiac disease ) ; documented prior stroke

2023-11-23 21:12:58 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 246).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
For Arm A or D : Any number of recurrences are allowable . For Arm B : First recurrence ( only ) WHO Grade glioma . First recurrence is defined as progression following initial therapy ( i.e. , radiation  chemotherapy ) . For participants who had prior therapy with radiation or chemotherapy for a low - grade glioma , the surgical diagnosis of a high - grade glioma will be considered the first recurrence . For patients who did not get additional treatment following surgery and diagnosis of low - grade glioma , surgical diagnosis of high grade glioma will not be considered the first recurrence . Instead , progression after treatment will be considered first recurrence . For Arm C : Patients must have clinical and/or radiographic evidence of first recurrence of glioblastoma and be eligible for salvage surgical resection as deemed by the site Investigator . For Arm E : Patients must have clinical and/or radiographic evidence of recurrence of diffuse midline glioma defined as a WHO Grade IV glioma involving the pons , thalamus or spinal cord , and be eligible for salvage surgical resection as deemed by the site Investigator

2023-11-23 21:12:58 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 183).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Histologically confirmed World Health Organization Grade IV glioblastoma . WHO Grade IV gliomas will be allowed on protocol . For Arm D : Must have a WHO Grade IV glioma as per above and tumor must harbor a histone H3 K27 M mutation as evidenced by testing any tumor sample with an immunohistochemistry or DNA sequencing test . For Arm E : Must have clinical and/or radiographic evidence of a diffuse midline glioma defined as a WHO Grade IV glioma involving the brainstem , thalamus or spinal cord and be eligible for salvage surgical resection as deemed by the site Investigator . For Arm F : Must have a diffuse midline glioma , defined as a WHO Grade IV glioma involving the brainstem , thalamus or spinal cord , without the H3 K27 M mutation or with unknown H3 mutation status

2023-11-23 21:12:59 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 150).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Adequate organ function as defined by : peripheral absolute neutrophil count ( ANC ) > /= 1,000 / mm3 , platelet count > /= 100,000 / mm3 ( transfusion independent defined as not receiving platelet transfusions within a 7 day period prior to enrollment ) , hemoglobin > /= 8.0g / dl ( may receive RBC transfusions ) , renal - creatinine < /= 2 x ULN ; hepatic- bilirubin and AST < /= 5x ULN ; pulmonary : FVC > /=50 % predicted , Oxyhemoglobin saturation at rest > /=95 % ( off supplemental oxygen )

2023-11-23 21:13:00 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 141).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients of childbearing potential must have a negative pregnancy test prior to the study entry and be practicing an effective form of contraception . Sexually active subjects must agree to use medically accepted barrier methods of contraception ( e.g. , male or female condom ) during the course of the study and for 4 months after the last dose of study drug , even if oral contraceptives are also used . All subjects of reproductive potential must agree to use both a barrier method and a second method of birth control during the course of the study and for 4 months after the last dose of study drug . Pregnant women are excluded from this study because of the potential for teratogenic or abortifacient effects

2023-11-23 21:13:00 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 165).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Present use or anticipated need for cytochrome P450 ( CYP ) 3A4 - inhibiting , CYP3A4 - inducing drugs ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , and voriconazole , rifampin , phenytoin , carbamazepine , rifabutin , rifapentin , phenobarbital , and St. John 's wort , bosentan , efavirenz , etravirine , modafinil , and nafcillin )

2023-11-23 21:13:01 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 145).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients must have histologically confirmed , metastatic or unresectable malignancy of the following types : ( a ) non - small cell lung cancer ( NSCLC ) , ( b ) triple - negative breast cancer ( TNBC ; defined by estrogen receptor [ ER ] < 1 % , progesterone receptor [ PR ] < 1 % and HER2 1 + or less by immunohistochemistry [ IHC ] ; if HER-2 expression is 2 + , a negative fluorescence in situ hybridization [ FISH ] testing is required ) ( c ) pancreatic adenocarcinoma ( PDAC ) , or ( d ) small cell lung cancer ( SCLC )

2023-11-23 21:13:02 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 173).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
For two weeks prior to first day of study drug treatment , administration of any of the following cytochrome P450 3A ( CYP3A ) inducers : phenytoin , phenobarbital , carbamazepine , rifampin , rifabutin , St. John 's Wort ; or CYP3A inhibitors : ketoconazole , itraconazole , nefazodone , ritonavir , nelfinavir , indinavir , atazanavir amprenavir , fosamprenavir , boceprevir , clarithromycin , conivaptan , lopinavir , posaconazole , saquinavir , telaprevir , telithromycin , or voriconazole

2023-11-23 21:13:02 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 131).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
OR Myelodysplastic syndrome ( MDS ) with excess blasts ( > 5 % ) and progressive disease at any time after initiation of DNA hypomethylator treatment during the past 2 years , OR failure to achieve complete or partial response or hematological improvement ( see section 12.4 ) after at least six cycles of azacytidine or four cycles of decitabine administered during the past 2 years , OR intolerance to azacytidine or decitabine . MDS patients with isolated 5q- abnormalities that meet these criteria after lenalidomide therapy and DNA hypomethylator therapy are also eligible

2023-11-23 21:13:02 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 138).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
currently receiving any of the following medications and can not be discontinued 7 days prior to starting study drug : a. Known strong inducers or inhibitors of CYP3A4/5 , including grapefruit , grapefruit hybrids , pummelos , star - fruit , and Seville oranges . b. That have a narrow therapeutic window and are predominantly metabolized through CYP3A4/5 . c. Herbal preparations / medications , dietary supplements . d. Hormone replacement therapy , topical estrogens ( including any intra - vaginal preparations ) , megestrol acetate and selective estrogen - receptor modulators ( e.g. raloxifene )

2023-11-23 21:13:03 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 167).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
femoral endarterectomy with or without patch angioplasty involving the common femoral artery and/or profunda and/or proximal superficial artery . The index groin may have undergone prior procedures ( may be inflow or outflow for existing grafts ) , but the patient must have fully healed from the prior operation . May include patients with concomitant proximal and/or distal peripheral vascular intervention . The patch may be autogenous venous or arterial or prosthetic material such as bovine pericardium , dacron or polytetrafluoroethylene ( PTFE ) . Bilateral femoral endarterectomies are eligible for enrollment . The right and left groin incision would be randomized to the same dressing which is consistent with routine clinical practice

2023-11-23 21:13:04 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 143).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
CAD ( history of MI or angina with positive stress test and not revascularizable ) ii ) LV Ejection fraction < 40 % iii ) Symptomatic CHF ( NYHC Class II , III , or IV ) c ) Pulmonary disease i ) Home oxygen therapy ii ) FEV1 < 1.2 l / s iii ) Vital capacity < 50 % predicted iv ) PaCO2 > 45 mm Hg or < 60 mm Hg d ) Renal disease i ) ESRD on dialysis ii ) eGFR < 60 e ) Prior aortic surgery f ) Hostile abdomen g ) Portal hypertension ( ascites or varices ) h ) Coagulopathy

2023-11-23 21:13:06 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 141).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
DONOR : Unrelated Umbilical Cord Blood : The UCB unit with the least HLA disparity ( with the patient ) will be selected first ( i.e. , selection priority is 6/6 match > 5/6 match > 4/6 match ) ; additional UCB units then may be selected to achieve the required cell dose ; if a second unit is required , this unit will be the unit that most closely HLA matches the patient and meets minimum size criteria outlined below of at least 1.5 x 10 ^ 7 TNC / kg ( i.e. a smaller more closely matched unit will be selected over a larger less well matched unit as long as minimum criteria are met )

2023-11-23 21:13:07 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 232).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
acute myeloid leukemia ( AML ): a. first complete remission with high - risk features defined as : ( i ) greater than 1 cycle of induction therapy required to achieve remission ; ( ii ) preceding myelodysplastic syndrome ( MDS ) ; ( iii ) presence of FLT3 mutations or internal tandem duplication or other mutations associated with poor - risk AML ( e.g. DNMT3A , TET2 ) ; ( iv ) French - American - British Classification ( FAB ) M6 or M7 classification ; ( v ) adverse cytogenetics : -5 , deletion ( del ) 5q , -7 , del7q , abnormalities involving 3q , 9q , 11q , 20q , 21q , 17 , +8 or complex karyotype ( > 3 abnormalities ) ; ( vi ) treatment - related AML , or b. second or greater remission ; patients beyond second remission have to be in complete remission ( CR ) at transplant to be eligible , or c. primary induction failure with partial response to therapy who achieve adequate cytoreduction

2023-11-23 21:13:07 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 189).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Other drugs that will be reasons for exclusion include : antimuscarinics , nifedipine , parasympathomimetics , amantadine , amoxapine , antacids , antidiarrheals , anxiolytics , hypnotics , atomexetine , bupropion , cisapride , clozapine , cyclobenzaprine , digoxin , disopyramide , dronabinol ( THC ) , ethanol , maprotilline , memantine , metoclopramide , nabilone , olanzapine , opiate agonists , orphenadrine , phenothiazines , potassium salts , quinidine , sedating H1 - blockers , topiramate , tricyclic antidepressants , erthyromycin , ketoconazole , and tegaserod

2023-11-23 21:13:09 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients with history of any autoimmune disease : inflammatory bowel disease , ( including ulcerative colitis and Crohn 's Disease ) , rheumatoid arthritis , systemic progressive sclerosis ( scleroderma ) , systemic lupus erythematosus ( SLE ) autoimmune vasculitis ( e.g. , Wegener 's Granulomatosis ) , CNS or motor neuropathy considered to be of autoimmune origin ( e.g. , Guillian - Barre Syndrome , Myasthenia Gravis , Multiple Sclerosis )

2023-11-23 21:13:09 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 127).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
History of any autoimmune disease : inflammatory bowel disease , ( including ulcerative colitis and Crohn 's Disease ) , rheumatoid arthritis , systemic progressive sclerosis ( scleroderma ) , systemic lupus erythematosus ( SLE ) autoimmune vasculitis ( e.g. , Wegener 's Granulomatosis ) , CNS or motor neuropathy considered to be of autoimmune origin ( e.g. , Guillian - Barre Syndrome , Myasthenia Gravis , Multiple Sclerosis

2023-11-23 21:13:10 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 158).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
In sustained clinical remission for the last 6 months while receiving treatment with either etanercept , infliximab , or adalimumab , and greater than or equal to 1 DMARD ( methotrexate , hydroxychloroquine , sulfasalazine , leflunomide , minocycline , cyclosporine , azathioprine , gold , penicillamine ) . DAS28 should be less than 2.6 on each visit over the preceding 6 months , with at least one visit 2 - 4 months before enrollment . If there is no visit 6 months before enrollment , the nearest visit in the 6 - 12 month period before enrollment should be considered and have a DAS28 less than 2.6

2023-11-23 21:13:11 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 330).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Mother may or may not already be taking HCQ . This latter point was discussed with Dr. Nathalie Costedoat - Chalumeau , who has published extensively on measurement of HCQ . While it might be optimal for the mothers anticipating enrollment in the study to all have been on HCQ prior to conception , this is impractical . Some may never achieve pregnancy and not want to take HCQ unless they conceive ( especially those asymptomatic ) . On the other hand , women with SLE are likely to already be on HCQ and it would limit enrollment to exclude these patients if all must initiate HCQ only at enrollment in the first trimester . Although the accepted dogma is that HCQ requires several months for maximal efficacy in treating rheumatic disease , it is unknown whether this would apply to transplacental passage or fetal levels ( which are impossible to measure ) . Dr. Costedoat - Chalumeau suggests that HCQ is probably a three compartment model which includes the circulation , tissues and cells . In the circulation , the half life is approximately 7 days and in the tissues , it is 40 days . In Dr. Costedoat - Chalumeau 's experience , steady state blood levels of HCQ are achieved in 4 - 6 weeks . Thus , dosing the mother no later than 10 weeks gestation should provide sufficient fetal exposure before the vulnerable period of CHB which is generally accepted to span 18 - 24 wks . Furthermore , the placenta has to be formed for HCQ to gain access to the fetus and it may be effective quickly for the biology we are considering

2023-11-23 21:13:11 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 174).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Mothers must have a previous child with cardiac NL , defined herein as : the presence of heart block ( 1st , 2nd , or 3rd degree ) documented by electrocardiogram ( EKG ) , echocardiogram , pacemaker , or statement in the medical record , and/or ; presence of cardiac injury , which specifically includes autopsy evidence of a mononuclear infiltrate in the endocardium , myocardium , and pericardium and/or EFE on echocardiogram always associated with cardiac dysfunction . In PITCH , we included women with a prior child with rash ; however , recent data generated from the RRNL suggest that recurrence of CHB following rash is 11 % , not 18 % [ 34 ] . Thus , inclusion of previous rash could lead to a falsely lowered recurrence rate , and will therefore be excluded

2023-11-23 21:13:16 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 188).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Systemic treatment , within 14 days before the first dose of ixazomib , with strong inhibitors of cytochrome P450 , family 1 , subfamily A , polypeptide 2 ( CYP1A2 ) ( fluvoxamine , enoxacin , ciprofloxacin ) , strong inhibitors of cytochrome P450 , family 3 , subfamily A ( CYP3A ) ( clarithromycin , telithromycin , itraconazole , voriconazole , ketoconazole , nefazodone , posaconazole ) or strong CYP3A inducers ( rifampin , rifapentine , rifabutin , carbamazepine , phenytoin , phenobarbital ) , or use of ginkgo biloba or St. John 's wort

2023-11-23 21:13:16 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 137).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients with uncontrolled intercurrent illness including , but not limited to psychiatric illness / social situations that would limit compliance with study requirements , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , myocardial infarction in the past 6 months , invasive fungal infections , or active ( acute or chronic ) or uncontrolled severe infection , liver disease such as cirrhosis , decompensated liver disease , and active and chronic hepatitis ( i.e. , quantifiable HBV - DNA and/or positive HbsAg , quantifiable HCV - RNA )

2023-11-23 21:13:16 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 161).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients with uncontrolled intercurrent illness including , but not limited to psychiatric illness / social situations that would limit compliance with study requirements , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , myocardial infarction in the past 6 months , invasive fungal infections , or active ( acute or chronic ) or uncontrolled severe infection , liver disease such as cirrhosis , decompensated liver disease , and active and chronic hepatitis ( i.e. , quantifiable hepatitis B virus [ HBV]-DNA and/or positive hepatitis B surface antigen [ HbsAg ] , quantifiable hepatitis C virus [ HCV]-ribonucleic acid [ RNA ] )

2023-11-23 21:13:16 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 128).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Current or anticipated use within 7 days prior to first dose of study drug or anticipated use during the study of the following P gp inhibitors ( amiodarone , carvedilol , clarithromycin , cobicistat , darunavir , dronedarone , erythromycin , indinavir , itraconazole , ketoconazole , lapatinib , lopinavir , propafenone , quinidine , ranolazine , ritonavir , saquinavir , telaprevir , tipranavir , verapamil , and valspodar )

2023-11-23 21:13:17 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 140).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Current activity > 2 hrs / wk of moderate intensity exercise , temporary vascular access , uncontrolled diabetes mellitus , active vasculitis , active autoimmune disease , malignancy , severe obesity ( BMI > 35 ) , alcoholism or other recreational drug use , unstable cardiac disease ( abnormal exercise test , angina , uncontrolled arrhythmias or myocardial infarction within three months ) , peripheral vascular disease ( claudication with exercise ) , lung , liver or intestinal disease , those who are medically unstable and subjects who have received anabolic , catabolic or cytotoxic medications in the past 3 months

2023-11-23 21:13:18 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 167).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
the % of positive cells will be rated : 0 points ( pts ) , 0 to 5 % ; 2 pts , 6 to 50 % ; 3 pts , 50 % ; the staining intensity will be rated as follows : 1 pt , weak intensity ; 2 pts , moderate intensity ; 3 pts , strong intensity ; pts for expression and % of positive cells will be added ; an overall score will be assigned ; tumors to be categorized into 4 groups : negative ( overall score 0 ) , 5 % cells stained , regardless of intensity ; weak expression ( overall score 1 ) , 1 - 2 pts ; moderate expression ( overall score 2 ) , 3 - 4 pts ; and strong expression ( overall score 3 ) , 5 - 6 pts ; overall H - score of 3 or above will be defined as EphA2 overexpression in tumor cells

2023-11-23 21:13:19 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 132).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Participants must have histologically or cytologically confirmed and identified resectable primary squamous cell carcinoma of the oropharynx that is HPV 16 positive or positive for any high risk HPV subtype ( i.e. , 18 , 33 , 35 , etc . ) as determined by PCR at the central laboratory . Patients must have p16 + status as determined by IHC performed or reviewed at the central laboratory prior to consent . Both p16 and HPV status must be determined prior to post - surgical adjuvant treatment assignment . Tissue from the primary site must be available for biomarker studies after surgery

2023-11-23 21:13:19 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 194).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Prior or currently active autoimmune disease requiring management with immunosuppression . This includes inflammatory bowel disease , ulcerative colitis , Crohn 's disease , systemic vasculitis , scleroderma , psoriasis , multiple sclerosis , hemolytic anemia , immune - mediated thrombocytopenia , rheumatoid arthritis , systemic lupus erythematosus , Sjorgen 's syndrome , sarcoidosis , or other rheumatologic disease or any other medical condition or use of medication ( e.g. , corticosteroids ) which might make it difficult for the patient to complete the full course of treatments or to generate an immune response to vaccines . Asthma or chronic obstructive pulmonary disease that does not require daily systemic corticosteroids is acceptable . Any patients receiving steroids should be discussed with the PI to determine if eligible

2023-11-23 21:13:21 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 181).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
1st CR with high risk features for relapse ( including history of prior malignancy treated with chemotherapy or radiotherapy , or history of myelodysplastic syndrome , myeloproliferative disorder , chronic myelomonocytic leukemia , myelodysplastic syndrome [ MDS]/myeloproliferative neoplasm [ MPN ] or other hematologic malignancy thought to have evolved to AML [ i.e. , secondary AML , ( sAML ) ] ; high risk cytogenetics at diagnosis ; fms - related tyrosine kinase 3 [ FLT3 ] mutated at diagnosis ; or presence or minimal residual disease assessed by polymerase chain reaction [ PCR ] , cytogenetics , and/or flow cytometry at time of enrollment ) 2nd CR regardless of disease characteristics at the time of diagnosis

2023-11-23 21:13:21 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 132).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Treatment with potentially hepatotoxic medications ( statins ) ; strong inhibitors of CYP3A4 ( ketoconazole , itraconazole , clarithromycin , atazanavir , nefazodone , saquinavir , telithromycin , ritonavir , indinavir , nelfinavir , voriconazole ) , or CYP3A4 inducers ( e.g. , phenytoin , carbamazepine , rifampin , rifabutin , rifapentine , phenobarbital )

2023-11-23 21:13:21 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 138).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Chronic use of agents known to affect the immune system including glucocorticoid therapy within the past 6 months , methotrexate within the past 1 year , chemotherapy of any kind ( past or present ) , immunotherapy of any kind ( past or present ) , aspirin or non - steroidal anti - inflammatory drugs ( NSAIDs ) ( within the past 2 weeks ) , statins ( within the past 1 month ) , vaccinations ( within the past 2 weeks ) , topical steroids ( within the past 2 weeks ) , and antibiotics ( within the past two weeks ) unless otherwise approved by principal investigator or PI 's designee

2023-11-23 21:13:25 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 283).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Women in the vaccine - eligible age range can not have received vaccine prior to enrollment , but will be offered HPV vaccination at the end of the study ; in brief , we are interested in the efficacy of intervention in preventing HPV in the absence of HPV vaccination , since most women worldwide who might utilize intervention will not have been vaccinated ; this includes United States ( US ) women in the vaccine catch - up 19 - 26 year old age group ( beyond the age groups eligible for Vaccines for Children- funded vaccination ) who have so far had very low ( < 10 % ) vaccine uptake ; it also includes the entire group of US women > 26 years of age ; moreover , it includes women of all ages in developing countries , who most need an HPV prevention strategy , but may never be vaccinated ; it should be noted that delaying vaccination in women 19 - 26 years of age by one year is safe and reasonable , since there is insufficient data to establish a recommendation for or against universal vaccination in this age group as concluded by an American Cancer Society expert panel , which includes the Principal Investigator ( PI ) of this protocol , Dr. Mark Einstein ; it is anticipated that if the intervention gel is efficacious , HPV vaccinated women would need to be studied in a similar future trial with power analysis taking into account vaccine effectiveness as well

2023-11-23 21:13:26 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 151).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Cytology report with a High Grade Squamous Intra Epithelial Lesion HSIL or have histologically proven CIN 2/3 or CIN 3 diagnosed by cervical biopsy between 2 and 8 weeks prior to enrollment . For a patient to be eligible , the Cytology report must state High Grade Squamous Intra Epithelial Lesion HSIL or the pathology report must clearly state CIN 2/3 or CIN 3 or must state moderate - severe dysplasia , moderate severe dyskaryosis , severe dysplasia , or severe dyskaryosis . Patients with a diagnosis of CIN 2 alone or moderate dysplasia or dyskaryosis alone are not eligible for this study

2023-11-23 21:13:26 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 131).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients taking the following concurrent medications : astemizole , cisapride , salmeterol , alfuzosin , terfinadine , amiodarone , midazolam , quinadine , ergot derivatives , pimozide , rifampin , triazolam , warfarin , azithromycin , carbamezpine , cyclosporine , didanosine , fluticasone propionate , phenobarbital , phenytoin , trazadone , sirolimus , tacrolimus , and St. John 's wart

2023-11-23 21:13:26 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 141).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Using any medication known to have adverse effects on motor or cognitive function , including monoamine oxidase inhibitors , sympathomimetics , antipsychotic agents , modafinil , oxybutynin , tricyclic antidepressants , cholinesterase inhibitors and anticonvulsants other than gabapentin and pregabalin . The following are permitted if the patient has been on a stable dose for at least 6 weeks : short acting benzodiazepines ( qhs administration only ) , anti - spasmodics , selective serotonin reuptake inhibitors and serotonin - norepinephrine reuptake inhibitors

2023-11-23 21:13:26 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 188).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Current use of or anticipated requirement during the study of prohibited medication(s ) ( any investigational drug(s ) , Other anti - cancer therapy ( chemotherapy , radiation therapy , immunotherapy , biologic therapy , or hormone therapy other than for replacement ) , AR antagonists ( e.g. , bicalutamide , flutamide , nilutamide ) , 5 - alpha reductase inhibitors ( e.g. , finasteride , dutasteride ) , Androgens ( e.g. , testosterone , dihydroepiandrosterone ) , Herbal medication(s ) that may affect PSA levels ( e.g. , saw palmetto ) , Other herbal medications including , but not limited to : St. John 's wort , kava , ephedra ( ma huang ) , gingko biloba , yohimbe and ginseng )

2023-11-23 21:13:27 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 262).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients who have any severe and/or uncontrolled medical conditions such as : a ) unstable angina pectoris , symptomatic congestive heart failure , myocardial infarction = < 6 months prior to start of everolimus , serious uncontrolled cardiac arrhythmia , or any other clinically significant cardiac disease ; b ) symptomatic congestive heart failure of New York Heart Association class III or IV ; c ) active ( acute or chronic ) or uncontrolled severe infection ( not responding to antibiotics ) , liver disease such as cirrhosis , decompensated liver disease , and active and chronic hepatitis ( i.e. quantifiable hepatitis B virus - deoxyribonucleic acid [ HBV - DNA ] and/or positive hepatitis B surface antigen [ HbsAg ] , quantifiable hepatitis C virus - ribonucleic acid [ HCV - RNA ] ) ; d ) known severely impaired lung function ( spirometry and diffusing capacity of the lung for carbon monoxide [ DLCO ] 50 % or less of normal and oxygen [ O2 ] saturation 88 % or less at rest on room air ) ; e ) active , bleeding diathesis

2023-11-23 21:13:28 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 203).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Women of child - bearing potential ( WOCBP ) , defined as women physiologically capable of becoming pregnant , must use one additional highly effective methods of contraception in addition to the LIUD during the study and 8 weeks after ; acceptable effective contraception methods include combo of the following : a ) barrier methods of contraception : condom or occlusive cap ( diaphragm or cervical / vault caps ) with spermicidal foam / gel / film / cream/ vaginal suppository ; b ) total abstinence or ; c ) male / female sterilization ; women are considered post - menopausal and not of child - bearing potential if they have had 12 months of natural ( spontaneous ) amenorrhea with an appropriate clinical profile ( e.g. age appropriate , history of vasomotor symptoms ) or have had surgical bilateral oophorectomy ( with or without hysterectomy ) or tubal ligation > six weeks prior to randomization

2023-11-23 21:13:28 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 132).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The effects of AT13387 on the developing human fetus are unknown ; for this reason and because paclitaxel are known to be teratogenic ; women of child - bearing potential and men must agree to use adequate contraception prior to study entry , for the duration of study participation and 3 months after completion of study treatment administration ; adequate contraception includes methods such as oral contraceptives , double barrier method ( condom plus spermicide or diaphragm ) , or abstaining from sexual intercourse ; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study , she should inform her treating physician immediately

2023-11-23 21:13:28 - Transformer_NER - INFO - 
************** Example ************
input tokens: ['[CLS]', 'any', 'surgical', 'therapy', 'in', 'the', 'area', 'of', 'the', 'oral', 'cavity', 'or', 'ph', '##ary', '##nx', 'within', 'the', 'last', '2', 'weeks', '[SEP]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]']
input ids: [101, 2151, 11707, 7242, 1999, 1996, 2181, 1997, 1996, 8700, 17790, 2030, 6887, 5649, 26807, 2306, 1996, 2197, 1016, 3134, 102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
label: [1, 3, 31, 30, 3, 3, 3, 3, 3, 3, 3, 3, 3, 2, 2, 3, 3, 33, 32, 32, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
mask: [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
segment ids: [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
guards: [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12, 12, 13, 14, 15, 16, 17, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
***********************************
            
2023-11-23 21:13:28 - Transformer_NER - INFO - 
************** Example ************
input tokens: ['[CLS]', 'any', 'tumor', 'stage', ',', 'any', 'n', ',', 'm', '##0', '[SEP]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]']
input ids: [101, 2151, 13656, 2754, 1010, 2151, 1050, 1010, 1049, 2692, 102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
label: [1, 3, 10, 3, 3, 3, 3, 3, 3, 2, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
mask: [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
segment ids: [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
guards: [0, 1, 2, 3, 4, 5, 6, 7, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
***********************************
            
2023-11-23 21:13:28 - Transformer_NER - INFO - 
************** Example ************
input tokens: ['[CLS]', 'eco', '##g', 'performance', 'status', '0', 'or', '1', '[SEP]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]']
input ids: [101, 17338, 2290, 2836, 3570, 1014, 2030, 1015, 102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
label: [1, 15, 2, 14, 14, 25, 3, 33, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
mask: [1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
segment ids: [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
guards: [0, 1, 1, 2, 3, 4, 5, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
***********************************
            
2023-11-23 21:13:30 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 170).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
MRI contraindications including : cardiac pacemaker , metal fragments in eyes / skin / body ( shrapnel ) , aortic / aneurysm clips , prosthesis , by - pass surgery / coronary artery clips , hearing aid , heart valve replacement , shunt ( ventricular or spinal ) , electrodes , metal plates / pins / screws/ wires , or neuro / bio - stimulators ( TENS unit ) , persons who have ever been a professional metal worker / welder , history of eye surgery / eyes washed out because of metal , vision problems uncorrectable with lenses , inability to lie still on one 's back for 60 - 120 minutes ; prior neurosurgery ; tattoos or cosmetic makeup with metal dyes , unwillingness to remove body piercings , and pregnancy

2023-11-23 21:13:32 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 171).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Caution should be exercised when administering paclitaxel ( Taxol ) concomitantly with medicines known to inhibit ( e.g. ketoconazole and other imidazole antifungals , erythromycin , fluoxetine , gemfibrozil , cimetidine , ritonavir , saquinavir , indinavir and nelfinavir ) OR induce ( e.g. rifampicin , carbamazepine , phenytoin , efavirenz and nevirapine ) either CYP2C8 or CYP3A4 . Based on the in vitro data and SimCYP simulations , selumetinib is considered unlikely to perpetrate clinically significant drug - drug interaction via inhibition or induction of CYP enzymes

2023-11-23 21:13:33 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 160).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Anti - Convulsants : carbamazepine , Phenobarbital , Anti - Convulsant : phenytoin , Anti - Mycobacterial : rifabutin , PDE5 Inhibitors : sildenafil , vardenafil , tadalafil , HMG - CoA : Reductase Inhibitors : atorvastatin , rosuvastatin , Immuno - suppressants : cyclosporine , tacrolimus , sirolimus , Narcotic Analgesic : methadone , Oral Contraceptive : ethinyl estradiol , Macrolide Antibiotic : azithromycin , Inhaled / nasal steroid fluticasone , Antidepressant : trazodone

2023-11-23 21:13:34 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 162).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
NHL : No clinical evidence of disease or disease - related symptoms ; Typically FDG - avid lymphomas : a post - treatment residual mass of any size is permitted as long as it is PET negative ; Variably FDG - avid lymphoma / FDG avidity unknown : all lymph nodes normal size by CT ; Spleen and liver non - palpable and without nodules ; If pretreatment bone marrow biopsy was positive , repeat bone marrow biopsy must be negative ; if morphologically indeterminate , immunohistochemistry should be negative If pretreatment bone marrow biopsy was positive , repeat bone marrow biopsy must be negative ; if morphologically indeterminate , immunohistochemistry should be negative

2023-11-23 21:13:34 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 132).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Current or history of treatment with medications that may cause significant weight gain , within 1 month prior to screening for this trial , including systemic corticosteroids ( except for a short course of treatment , i.e. , 7- 10 days ) , tri - cyclic antidepressants , atypical antipsychotic and mood stabilizers ( e.g. , imipramine , amitryptiline , mirtazapine , paroxetine , phenelzine , clorpromazine , thioridazine , clozapine , olanzapine , valproic acid and its derivatives , and lithium )

2023-11-23 21:13:39 - Transformer_NER - INFO - ***** Running training *****
2023-11-23 21:13:39 - Transformer_NER - INFO -   Num data points = 5043
2023-11-23 21:13:39 - Transformer_NER - INFO -   Num Epochs = 20.0
2023-11-23 21:13:39 - Transformer_NER - INFO -   Instantaneous batch size per GPU = 8
2023-11-23 21:13:39 - Transformer_NER - INFO -   Gradient Accumulation steps = 1
2023-11-23 21:13:39 - Transformer_NER - INFO -   Total optimization steps = 100860.0
2023-11-23 21:13:39 - Transformer_NER - INFO -   Training steps (number of steps between two evaluation on dev) = 1000
2023-11-23 21:13:39 - Transformer_NER - INFO - ******************************
2023-11-23 21:40:41 - Transformer_NER - INFO - Task will use CPU.
2023-11-23 21:40:41 - Transformer_NER - WARNING - set tokenizer as bert-base-uncased
2023-11-23 21:40:41 - Transformer_NER - WARNING - set config as bert-base-uncased
2023-11-23 21:40:42 - Transformer_NER - INFO - Training/evaluation parameters: {'model_type': 'bert', 'pretrained_model': 'bert-base-uncased', 'resume_from_model': None, 'config_name': 'bert-base-uncased', 'tokenizer_name': 'bert-base-uncased', 'data_dir': './fbner', 'data_has_offset_information': True, 'new_model_dir': './new_bert_ner_model', 'save_model_core': True, 'predict_output_file': None, 'overwrite_model_dir': True, 'seed': 13, 'max_seq_length': 128, 'do_train': True, 'model_selection_scoring': 'strict-f_score-1', 'do_predict': False, 'use_crf': False, 'do_lower_case': True, 'train_batch_size': 8, 'eval_batch_size': 8, 'train_steps': 1000, 'learning_rate': 1e-05, 'min_lr': 1e-06, 'num_train_epochs': 20.0, 'gradient_accumulation_steps': 1, 'do_warmup': True, 'warmup_ratio': 0.1, 'weight_decay': 0.0, 'adam_epsilon': 1e-08, 'max_grad_norm': 1.0, 'max_num_checkpoints': 1, 'log_file': './log.txt', 'log_lvl': 'i', 'progress_bar': True, 'early_stop': 3, 'focal_loss': False, 'focal_loss_gamma': 2, 'use_biaffine': False, 'mlp_dim': 128, 'mlp_layers': 0, 'mlp_hidden_dim': 0, 'adversarial_training_method': None, 'fp16': False, 'logger': <Logger Transformer_NER (INFO)>, 'device': device(type='cpu'), 'num_labels': 34, 'label2idx': {'O': 3, 'X': 2, 'PAD': 0, 'CLS': 1, 'I-age': 4, 'B-age': 5, 'I-allergy_name': 6, 'B-allergy_name': 7, 'I-bmi': 8, 'B-bmi': 9, 'B-cancer': 10, 'I-cancer': 11, 'B-chronic_disease': 12, 'I-chronic_disease': 13, 'B-clinical_variable': 14, 'I-clinical_variable': 15, 'B-contraception_consent': 16, 'I-contraception_consent': 17, 'I-ethnicity': 18, 'B-ethnicity': 19, 'B-gender': 20, 'I-gender': 21, 'I-language_fluency': 22, 'B-language_fluency': 23, 'I-lower_bound': 24, 'B-lower_bound': 25, 'I-pregnancy': 26, 'B-pregnancy': 27, 'I-technology_access': 28, 'B-technology_access': 29, 'B-treatment': 30, 'I-treatment': 31, 'I-upper_bound': 32, 'B-upper_bound': 33}, 'idx2label': {3: 'O', 2: 'X', 0: 'PAD', 1: 'CLS', 4: 'I-age', 5: 'B-age', 6: 'I-allergy_name', 7: 'B-allergy_name', 8: 'I-bmi', 9: 'B-bmi', 10: 'B-cancer', 11: 'I-cancer', 12: 'B-chronic_disease', 13: 'I-chronic_disease', 14: 'B-clinical_variable', 15: 'I-clinical_variable', 16: 'B-contraception_consent', 17: 'I-contraception_consent', 18: 'I-ethnicity', 19: 'B-ethnicity', 20: 'B-gender', 21: 'I-gender', 22: 'I-language_fluency', 23: 'B-language_fluency', 24: 'I-lower_bound', 25: 'B-lower_bound', 26: 'I-pregnancy', 27: 'B-pregnancy', 28: 'I-technology_access', 29: 'B-technology_access', 30: 'B-treatment', 31: 'I-treatment', 32: 'I-upper_bound', 33: 'B-upper_bound'}}
2023-11-23 21:40:44 - Transformer_NER - INFO - New Model Config:
BertConfig {
  "architectures": [
    "BertForMaskedLM"
  ],
  "attention_probs_dropout_prob": 0.1,
  "classifier_dropout": null,
  "focal_loss_gamma": 2,
  "gradient_checkpointing": false,
  "hidden_act": "gelu",
  "hidden_dropout_prob": 0.1,
  "hidden_size": 768,
  "id2label": {
    "0": "LABEL_0",
    "1": "LABEL_1",
    "2": "LABEL_2",
    "3": "LABEL_3",
    "4": "LABEL_4",
    "5": "LABEL_5",
    "6": "LABEL_6",
    "7": "LABEL_7",
    "8": "LABEL_8",
    "9": "LABEL_9",
    "10": "LABEL_10",
    "11": "LABEL_11",
    "12": "LABEL_12",
    "13": "LABEL_13",
    "14": "LABEL_14",
    "15": "LABEL_15",
    "16": "LABEL_16",
    "17": "LABEL_17",
    "18": "LABEL_18",
    "19": "LABEL_19",
    "20": "LABEL_20",
    "21": "LABEL_21",
    "22": "LABEL_22",
    "23": "LABEL_23",
    "24": "LABEL_24",
    "25": "LABEL_25",
    "26": "LABEL_26",
    "27": "LABEL_27",
    "28": "LABEL_28",
    "29": "LABEL_29",
    "30": "LABEL_30",
    "31": "LABEL_31",
    "32": "LABEL_32",
    "33": "LABEL_33"
  },
  "initializer_range": 0.02,
  "intermediate_size": 3072,
  "label2id": {
    "LABEL_0": 0,
    "LABEL_1": 1,
    "LABEL_10": 10,
    "LABEL_11": 11,
    "LABEL_12": 12,
    "LABEL_13": 13,
    "LABEL_14": 14,
    "LABEL_15": 15,
    "LABEL_16": 16,
    "LABEL_17": 17,
    "LABEL_18": 18,
    "LABEL_19": 19,
    "LABEL_2": 2,
    "LABEL_20": 20,
    "LABEL_21": 21,
    "LABEL_22": 22,
    "LABEL_23": 23,
    "LABEL_24": 24,
    "LABEL_25": 25,
    "LABEL_26": 26,
    "LABEL_27": 27,
    "LABEL_28": 28,
    "LABEL_29": 29,
    "LABEL_3": 3,
    "LABEL_30": 30,
    "LABEL_31": 31,
    "LABEL_32": 32,
    "LABEL_33": 33,
    "LABEL_4": 4,
    "LABEL_5": 5,
    "LABEL_6": 6,
    "LABEL_7": 7,
    "LABEL_8": 8,
    "LABEL_9": 9
  },
  "label2idx": {
    "B-age": 5,
    "B-allergy_name": 7,
    "B-bmi": 9,
    "B-cancer": 10,
    "B-chronic_disease": 12,
    "B-clinical_variable": 14,
    "B-contraception_consent": 16,
    "B-ethnicity": 19,
    "B-gender": 20,
    "B-language_fluency": 23,
    "B-lower_bound": 25,
    "B-pregnancy": 27,
    "B-technology_access": 29,
    "B-treatment": 30,
    "B-upper_bound": 33,
    "CLS": 1,
    "I-age": 4,
    "I-allergy_name": 6,
    "I-bmi": 8,
    "I-cancer": 11,
    "I-chronic_disease": 13,
    "I-clinical_variable": 15,
    "I-contraception_consent": 17,
    "I-ethnicity": 18,
    "I-gender": 21,
    "I-language_fluency": 22,
    "I-lower_bound": 24,
    "I-pregnancy": 26,
    "I-technology_access": 28,
    "I-treatment": 31,
    "I-upper_bound": 32,
    "O": 3,
    "PAD": 0,
    "X": 2
  },
  "layer_norm_eps": 1e-12,
  "max_position_embeddings": 512,
  "mlp_dim": 128,
  "model_type": "bert",
  "num_attention_heads": 12,
  "num_hidden_layers": 12,
  "pad_token_id": 0,
  "position_embedding_type": "absolute",
  "transformers_version": "4.24.0",
  "type_vocab_size": 2,
  "use_cache": true,
  "use_crf": false,
  "use_focal_loss": false,
  "vocab_size": 30522
}

2023-11-23 21:40:47 - Transformer_NER - INFO - 
************** Example ************
input tokens: ['[CLS]', 'eligible', 'to', 'undergo', 'ex', '##cision', '##al', 'surgery', 'such', 'as', 'pl', '##eur', '##ect', '##omy', '/', 'decor', '##tica', '##tion', '(', 'p', '/', 'dc', ')', 'or', 'any', 'other', 'me', '##so', '##the', '##lio', '##ma', 'surgery', '[SEP]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]']
input ids: [101, 7792, 2000, 13595, 4654, 28472, 2389, 5970, 2107, 2004, 20228, 11236, 22471, 16940, 1013, 25545, 22723, 3508, 1006, 1052, 1013, 5887, 1007, 2030, 2151, 2060, 2033, 6499, 10760, 12798, 2863, 5970, 102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
label: [1, 3, 3, 3, 30, 2, 2, 31, 3, 3, 30, 2, 2, 2, 31, 31, 2, 2, 31, 31, 31, 31, 31, 3, 3, 3, 30, 2, 2, 2, 2, 31, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
mask: [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
segment ids: [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
guards: [0, 1, 2, 3, 4, 4, 4, 5, 6, 7, 8, 8, 8, 8, 9, 10, 10, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 19, 19, 19, 19, 20, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
***********************************
            
2023-11-23 21:40:47 - Transformer_NER - INFO - 
************** Example ************
input tokens: ['[CLS]', 'his', '##to', '##logical', '##ly', 'confirmed', 'mali', '##gnant', 'pl', '##eur', '##al', 'me', '##so', '##the', '##lio', '##ma', 'that', 'is', 'not', 'meta', '##static', 'or', 'un', '##res', '##ect', '##able', '[SEP]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]']
input ids: [101, 2010, 3406, 9966, 2135, 4484, 16007, 27881, 20228, 11236, 2389, 2033, 6499, 10760, 12798, 2863, 2008, 2003, 2025, 18804, 16677, 2030, 4895, 6072, 22471, 3085, 102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
label: [1, 3, 2, 2, 2, 3, 3, 2, 10, 2, 2, 11, 2, 2, 2, 2, 3, 3, 3, 10, 2, 3, 3, 2, 2, 2, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
mask: [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
segment ids: [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
guards: [0, 1, 1, 1, 1, 2, 3, 3, 4, 4, 4, 5, 5, 5, 5, 5, 6, 7, 8, 9, 9, 10, 11, 11, 11, 11, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
***********************************
            
2023-11-23 21:40:47 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 136).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
This includes inflammatory bowel disease , ulcerative colitis , Crohn 's disease , systemic vasculitis , scleroderma , psoriasis , multiple sclerosis , hemolytic anemia , immune - mediated thrombocytopenia , rheumatoid arthritis , systemic lupus erythematosus , Sjogren 's syndrome , sarcoidosis , or other rheumatologic disease or any other medical condition or use of medication ( e.g. , corticosteroids ) which might make it difficult for the patient to complete the full course of treatments or to generate an immune response to vaccines

2023-11-23 21:40:48 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 129).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Advanced stage cutaneous T - cell lymphoma ( CTCL ) , specifically CTCL NOS , small / medium T - cell lymphoma ( SMTCL ) and mycosis fungoides ( MF ) stage IB , IIA , IIB , III and IV that have relapsed after at least one specific prior therapy ( e.g. interferon , photopheresis , denileukin difitox , bexarotene , etc ) ; anaplastic cutaneous large cell lymphoma ( ACLCL ) and lymphomatoid papulopsis

2023-11-23 21:40:49 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 153).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
All potential patients must undergo a tuberculosis ( TB ) test prior to study entry to rule out active or latent tuberculosis ( either purified protein derivative [ PPD ] or QuantiFERON - TB Gold , whichever is preferred and available at the institution ) ; patients with a history of TB ( even if treated ) , or evidence of active or latent TB , are excluded ; the diagnosis of active TB is defined per current guidelines ; patients with a positive TB test ( e.g. PPD or QuantiFERON - TB Gold ) will be excluded ; patients with history of Bacille - Calmette - Guerin ( BCG ) vaccination will be tested with QuantiFERON - TB Gold test in order to rule out exposure to TB

2023-11-23 21:40:49 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 157).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients must have relapsed ( recurrence after complete response or presented progression after partial response ) after last rituximab - containing therapy ( other previous treatment lines after rituximab are allowed ) . A previous regimen is defined as one of the following : at least 2 months of single - agent therapy ( less than 2 months of therapy is allowed for patients who responded to single - agent rituximab ) ; at least 2 consecutive cycles of polychemotherapy ; autologous transplant ; radioimmunotherapy . Previous exposure to PI3 K is acceptable ( except to copanlisib ) provided there is no resistance . Patients with prior intolerance to PI3 K inhibitors other than copanlisib are eligible

2023-11-23 21:40:51 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 144).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Pediatric Population ( patients < 18 years ): Creatinine within normal limits or calculated creatinine clearance greater than or equal to 90 ml / min/1.73 m2 as calculated by the Schwartz formula for estimated glomerular filtration rate ( GFR ) where GFR ( ml / min/1.73 m2 ) = k x Height ( cm)/serum creatinine ( mg / dl ) . k is a proportionality constant which varies with age and is a function of urinary creatinine excretion per unit of body size ; 0.45 up to 12 months of age ; 0.55 children and adolescent girls ; and 0.70 adolescent boys

2023-11-23 21:40:52 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 154).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
RB proficiency means that there is an intact RB pathway indicative of responsiveness to PD-0332991 . RB staining is scored on an absent ( no nuclear staining ) , weak ( nuclear staining less than observed in endothelial cells and stromal cells surrounding the tumor ) , positive ( nuclear staining at or above surrounding tissue ) ( 0 , 0.5 , 1 respectively ) . P16ink4a is a routine clinical stain that is scored using absent , weak , positive , strong ( 0,1,2,3 respectively ) . Tumors will be scored using [ p16]/[RB ] , where a score of less than 3 is required for inclusion . RB loss is expected to occur in less than 15 % of cases

2023-11-23 21:40:54 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Baseline lab values at the time of consent of : white blood cells ( K / uL ) > 14 or < 2 , hematocrit < 30 , platelets ( K / uL ) < 30,000 , non - pharmacologic INR > 1.7 , CA19 - 9 > 2X ULN(unit / ml ) , lipase ( U / L ) > 2 X the upper limit of normal , creatinine ( mg / dl ) > 3.0 unless stable on renal replacement therapy , ALT ( U / L ) > 500 , total bilirubin ( mg / dl ) > 2.5

2023-11-23 21:40:57 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 189).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The effects of onalespib and AT7519 M on the developing human fetus are unknown ; for this reason , women of childbearing potential and male patients with partners of childbearing potential must agree to use adequate contraception ( hormonal or barrier method of birth control or abstinence ) prior to study entry , for the duration of study participation , and for 2 months after completion of study ; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study , she should inform her treating physician immediately ; women of childbearing potential enrolling on study must have a negative pregnancy test within 72 hours of enrollment in order to be eligible ; because there is an unknown but potential risk to nursing infants secondary to treatment of the mother with onalespib and AT7519 M , breastfeeding should be discontinued while the mother is treated with onalespib and AT7519 M

2023-11-23 21:40:59 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 191).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Treatment , either current or within 28 days prior to Randomization , with any medications having a potential effect on alcohol consumption and related behaviors or mood . These include opioid antagonists ( e.g. , naltrexone , Vivitrol  , Selincro  ) , glutamate antagonists ( e.g. , acamprosate ) , anticonvulsants ( e.g. , topiramate , gabapentin ) , serotonin reuptake inhibitors ( e.g. , fluoxetine ) , serotonin antagonists ( e.g. , buspirone ) , other antidepressants ( e.g. , tricyclic antidepressants or monoamine oxidase inhibitors ) , dopamine antagonists ( e.g. , haloperidol ) , and disulfiram ( Antabuse  )

2023-11-23 21:41:01 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 129).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Refractory myositis patients are defined ( see Section 3.1.1 ) as having failed ( or considered intolerant to ) an adequate course of glucocorticoids or having failed glucocorticoids and at least one other immunosuppressive ( IS ) or immunomodulatory agent ( e.g. methotrexate , azathioprine , cyclosporine , tacrolimus , mycophenolate mofetil , cyclophosphamide , IVIg , anti - TNF agents , and rituximab )

2023-11-23 21:41:02 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 149).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Individuals currently taking alpha blockers ( terazosin , prazosin ) , hypnotics / benzodiazepines , atypical antipsychotics ( olanzapine , quetiapine , risperidone , clozapine ) , alpha-2 - agonists ( Clonidine , methyldopa , tizanidine , guanfacine ) , conivaptan , boceprevir , idelalisib , PDE-5 inhibitors or alpha-1 - antagonists , protease inhibitors ( treatment of HIV ) , oral antifungals , alfuzosin , pazopanib , silodosin , tadalafil , or tamulosin

2023-11-23 21:41:02 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 158).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
MRI exclusions : Claustrophobia ; tattoos above the shoulders after evaluation by MRI technician ; permanent eyeliner or permanent artificial eyebrows ; cardiac pacemaker ; metal fragments in eye , skin , or body , including shrapnel ; heart valve replacement ; brain clips ; venous umbrella ; being a sheet - metal worker or welder ; lifetime history of aneurysm surgery ; intracranial bypass , renal , or aortic clips ; prosthetic devices such as middle ear , eye , joint , or penile implants ; joint replacements ; non - removable hearing aid , neurostimulator , or insulin pump ; shunts / stents ; metal mesh / coil implants ; metal plate / pin / screws / wires ; or any other metal implants

2023-11-23 21:41:03 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 136).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Meet criteria for the following psychiatric and/or substance use disorders as assessed by the MINI International Neuropsychiatric Interview ( MINI ): items C ( current manic or hypomanic episode only ) , I ( alcohol abuse - Alcohol Addendum - past 6 months only ; current alcohol dependence ) , J ( substance abuse - Substance Abuse Addendum - past 6 months only ; current substance dependence ) , K ( current / lifetime psychotic disorder or current / lifetime mood disorder with psychotic features ) ; individuals who meet criteria for non - exclusionary psychiatric disorders that are considered clinically unstable and/or unsuitable to participate as determined by the principal investigator and/or study physician

2023-11-23 21:41:04 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 225).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The effects of the drugs used in this trial on the developing human fetus are unknown ; however , cabozantinib was embryolethal in rats at exposures below the 140 mg dose in the label , with increased incidences of skeletal variations in rats and visceral variations and malformations in rabbits ; for this reason and because tyrosine kinase inhibitors agents as well as other therapeutic agents used in this trial are known to be teratogenic , women of child - bearing potential and men must agree to use adequate contraception , as defined below , prior to study entry and for the duration of study participation ; should a woman become pregnant or suspect she is pregnant while she is participating in this study , she should inform her treating physician immediately ; men treated or enrolled on this protocol must also agree to use adequate contraception prior to the study , for the duration of study participation , and 7 months after completion of all study medications ; women treated or enrolled on this protocol must also agree to use adequate contraception prior to the study , for the duration of study participation , and for 5 months after completion of all study medications

2023-11-23 21:41:04 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 194).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Women of child bearing potential and male patients who are not surgically sterile must be willing to practice contraceptive methods for the duration of the study and for 30 - days following the last dose of study medication . Female patients must be postmenopausal ( greater than 12 months from onset of menopause ) or surgically sterile ( have undergone bilateral oophorectomy or hysterectomy ) . Women of child bearing potential and women < 12 months since onset of menopause must agree to use an acceptable contraception method . If employing contraception , 2 of the following precautions must be used : vasectomy of partner , tubal ligation , vaginal diaphragm , intrauterine device , oral contraceptives ( same oral contraceptive for a minimum of 3 months prior to screening ) , birth control injections , birth control implant , condom and spermicidal ( gel / foam / cream / vaginal suppository )

2023-11-23 21:41:06 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 239).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients at risk for endovascular infection ( previously documented rheumatic heart disease , congenital valve disease , surgically repaired congenital heart disease , unrepaired cyanotic congenital heart disease , any intracardiac repair with prosthetic material [ mechanical or bio - prosthetic cardiac valves ] , previous or current endocarditis , permanent endovascular devices ( e.g. , endovascular grafts [ e.g. , aortic aneurysm repair , stents involving large arteries such as aorta , femorals and carotids ] , inferior vena cava filters , dialysis vascular grafts ) , tunnelled ( not short - term ) hemodialysis catheters , pacemakers or defibrillators . Patients with temporary central venous catheters , central venous dialysis catheters or peripherally inserted central catheters ( PICCs ) are not excluded and patients with coronary artery stents , coronary artery bypass grafts ( CABG ) or neurovascular coils are not excluded ; patients with mitral valve prolapse or bicuspid aortic valve

2023-11-23 21:41:06 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 276).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients must have relapsed after high - dose therapy and autologous transplantation or be ineligible for high - dose therapy and autologous transplantation ; patients that have failed autologous transplantation are those with persistent disease > 30 days after transplant ; those ineligible for autologous transplant include those with chemoresistant disease ( i.e. , patients who have not achieved a partial response or better with their most recent chemotherapy regimen ) , are expected to have a poor outcome from autologous transplant ( e.g. , DLBCL relapsing within one year of rituximab , cyclophosphamide , doxorubicin hydrochloride , vincristine sulfate , prednisone [ R - CHOP]-like chemotherapy , double hit lymphoma , v - myc myelocytomatosis viral oncogene homolog ( avian ) positive [ MYC+ ] lymphoma , persistent positron emission tomography [ PET ] positivity after chemotherapy ) , are unable to collect sufficient or tumor - free autologous stem cells per Seattle Cancer Care Alliance ( SCCA ) standard practice , are unable to tolerate the high - dose autologous conditioning regimens , or who refuse a high - dose autologous transplant regimen

2023-11-23 21:41:07 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 135).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
3 of 5 criteria : ( i ) Elevated erythrocyte sedimentation rate ( ESR ) ( > 30mm / jr ) and c - reactive protein ( CRP ) ( > 10mg / L ) ( ii ) Elevated synovial leukocyte count ( > 3000 cells/L ) or change of + + on leukocyte esterase strip ( iii ) Elevated synovial neutrophil percentage ( > 80 % ) ( iv ) One positive culture ( v ) Positive histological analysis of periprosthetic tissue ( > 5 neutrophils per high power field in 5 high power fields x400 )

2023-11-23 21:41:12 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 127).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Prior open surgical or interventional procedure within 30 days of the anticipated date of the fenestrated - branched procedure , with the exception of planned staged procedures to provide access for repair ( e.g. staged iliac conduit , cervical debranching , elephant trunk repair ) , to facilitate the procedure by allowing open revascularization of a target artery not amenable to revascularization with the investigational device , such as an internal iliac artery , subclavian artery or visceral artery with early bifurcation , tortuosity or occlusive disease preventing successful placement of alignment side stents

2023-11-23 21:41:12 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 151).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Food or drugs that are known to be CYP3A4 inhibitors ( e.g. grapefruit juice , verapamil , ketoconazole , miconazole , itraconazole , erythromycin , clarithromycin , telithromycin , indinavir , ritonavir , nelfinavir , atazanavir , amprenavir , nefazodone , diltiazem , and delavirdine ) or inducers ( i.e. dexamethasone , glucocorticoids , progesterone , rifampin , phenobarbital , St. John 's wort )

2023-11-23 21:41:13 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 151).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
antivirals ( except for treatment of HSV with agents without CNS activity , e.g. acyclovir , ganciclovir , famciclovir , valacyclovir ) ; anxiolytics ; cough / cold preparations ( dextromethorphan preparations , pseudoephedrine ) ; hormones ( exceptions : thyroid hormone replacement , oral contraceptives , and estrogen replacement therapy ) ; insulin ; lithium ; muscle relaxants ; psychotropic drugs not otherwise specified ( nos ) including herbal products ( no drugs with psychomotor effects or with anxiolytics , stimulant , antipsychotic , or sedative properties ) ; sedatives / hypnotics

2023-11-23 21:41:14 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 147).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Strong CYP3A4 inhibitors : ( Patients must discontinue drug 7 days prior to starting ruxolitinib ) , including but not limited to boceprevir , clarithromycin , conivaptan , indinavir , itraconazole , ketoconazole , lopinavir , mibefradil , nefazodone , nelfinavir , posaconazole , ritonavir , saquinavir , telaprevir , telithromycin , or voriconazole . In addition , patients will be instructed to avoid grapefruit or grapefruit juice , starfruit , or seville oranges

2023-11-23 21:41:17 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 178).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
On scheduled strong or moderate CYP3A4 inhibitors ( boceprevir , clarithromycin , conivaptan , indinavir , itraconazole , ketoconazole , lopinavir / ritonavir , mibefradil , nefazodone , nelfinavir , posaconazole , ritonavir , saquinavir , telaprevir , telithromycin , voriconazole ; amprenavir , aprepitant , atazanavir , ciprofloxacin , darunavir / ritonavir , diltiazem , erythromycin , fluconazole , fosamprenavir , grapefruit juice , imatinib , verapamil ) within one week of study enrollment

2023-11-23 21:41:21 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 129).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients with symptomatic brain metastases should be excluded from this clinical trial because of their poor prognosis and because they often develop progressive neurologic dysfunction that would confound the evaluation of neurologic and other adverse events . However , patients who have had treatment for their brain metastases and whose brain metastatic disease status has remained stable for at least 1 week after the end of brain radiation may be enrolled to undergo molecular profiling at the discretion of the principal investigator . In addition , brain metastatic disease should be stable for at least 4 weeks , before the patients can be enrolled in any of the experimental treatment arms

2023-11-23 21:41:21 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 139).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The eligibility of patients taking medications that are potent inducers or inhibitors of that enzyme will be determined following a review of their case by the Principal Investigator . ( A list of potent CYP3A4 inducers or inhibitors can be found in Appendix F ) . Every effort should be made to switch patients taking such agents or substances to other medications before they begin treatment with one of the experimental drug included in this protocol , particularly patients with gliomas or brain metastases who are taking enzyme - inducing anticonvulsant agents . A comprehensive list of medications and substances known or with the potential to alter the pharmacokinetics of sunitinib through CYP3A4

2023-11-23 21:41:23 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 187).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The participating parent or child will not have had a concussion in the past three months ; will not have any significant developmental delays or intellectual disabilities ; will not be receiving treatment for a DSM-5 disorder that interferes with treatment delivered as part of the intervention ; will not have a physical disability or diagnosis that prevents performance of physical activity at a level equivalent to a brisk walk or that places severe restriction on diet ; will not be on a medication regimen that affects weight ; will not have a medical condition that alters nutritional status , intestinal absorption , or affects weight ; will not have undergone weight loss surgery ; and will not be participating in an alternate weight control program . Families in which either the participating child or parent is actively involved in other weight - loss treatment , is using weight - affecting medications , or has an impairing psychiatric or medical condition that would hinder participation in the study will be excluded as identified by the screening assessments

2023-11-23 21:41:24 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 170).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Impaired cardiac function or clinically significant cardiac diseases , including any of the following : history or presence of ventricular tachyarrhythmia ; presence of unstable atrial fibrillation ( ventricular response > 100 beats per minute [ bpm ] ) ; patients with stable atrial fibrillation are eligible , provided they do not meet any of the other cardiac exclusion criteria ; clinically significant resting bradycardia ( < 50 bpm ) ; angina pectoris or acute myocardial infarction = < 3 months prior to starting study drug ; other clinically significant heart disease ( e.g. , symptomatic congestive heart failure ; uncontrolled arrhythmia or hypertension ; history of labile hypertension or poor compliance with an antihypertensive regimen )

2023-11-23 21:41:24 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 134).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Subjects with evidence of severe or uncontrolled systemic disease , or any concurrent condition , which could compromise participation in the study , including , but not limited to , active or uncontrolled infection , immune deficiencies , Hepatitis B , Hepatitis C , uncontrolled diabetes , uncontrolled hypertension , symptomatic congestive heart failure , unstable angina pectoris , myocardial infarction within the past 6 months , uncontrolled cardiac arrhythmia , stroke / cerebrovascular accident within the past 6 months , or psychiatric illness / social situations which would jeopardize compliance with the protocol

2023-11-23 21:41:30 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 197).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Elective , open unilateral inguinal herniorrhaphy using Lichtenstein ( tension free with mesh ) hernia repair technique Agree to take only the prescribed oral analgesic medication ( oxycodone / acetaminophen ) , plus or minus ibuprofen , for the initial fourteen - day post - operative period , with allowed exception of any currently prescribed opioid ( codeine , hydrocodone , hydromorphone , morphine , methadone , oxymorphone , transdermal fentanyl ) , which can be continued . Agree to honestly complete a depression screening questionnaire , illicit drug use personal history and questionnaire , and physical activity assessment questionnaire , with the knowledge that if the patient is an active duty member , this information could result in a referral to medical or command authorities for potential Uniform Code of Military Justice ( UCMJ ) violations or concerns for subject health and fitness for duty

2023-11-23 21:41:34 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 134).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The investigators chose an upper eGFR limit slightly higher than the Kidney Disease Outcomes Quality Initiative ( KDOQI ) definition of moderately reduced glomerular filtration rate ( GFR ) to be more inclusive of patients with mild reduction in GFR but significant proteinuria . The lower eGFR limit was set to exclude patients with advanced CKD , where the potential effects of dietary sodium reduction on proteinuria may not be apparent or greatly alter CKD progression . The eGFR to define eligibility will be calculated using calibrated serum creatinine values and the Chronic Kidney Disease Epidemiology Collaboration ( CKD - EPI ) estimating equation

2023-11-23 21:41:34 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Have metal that would make an MRI scan unsafe such as : cardiac pacemaker , insulin infusion pump , implanted drug infusion devise , cochlear or ear implant , transdermal medication patch ( nitroglycerine ) , any metallic implants or objects , body piercing that can not be removed , bone or joint pin , screw , nail , plate , wire sutures or surgical staples , shunts , cerebral aneurysms clips , shrapnel or other metal embedded ( such as from war wounds or accidents or previous work in metal fields or machines that may have left any metallic fragments in or near your eyes )

2023-11-23 21:41:34 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Have a history of any autoimmune disease : inflammatory bowel disease , ( including ulcerative colitis and Crohn 's Disease ) , rheumatoid arthritis , systemic progressive sclerosis ( scleroderma ) , systemic lupus erythmatosus ( SLE ) autoimmune vasculitis ( e.g. , Wegener 's Granulomatosis ) , CNS or motor neuropathy considered to be of autoimmune origin ( e.g. , Guillian - Barre Syndrome , Myasthenia Gravis , Multiple Sclerosis )

2023-11-23 21:41:35 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 223).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients who have any severe and/or uncontrolled medical conditions such as : a. serious uncontrolled cardiac arrhythmia , or any other clinically significant cardiac disease b. active ( acute or chronic ) or uncontrolled severe infection , liver disease such as cirrhosis , decompensated liver disease , and active and chronic hepatitis ( i.e. quantifiable hepatitis B virus [ HBV]-deoxyribonucleic acid [ DNA ] and/or positive surface antigen of the hepatitis B virus [ HBsAg ] , quantifiable hepatitis C virus [ HCV]-ribonucleic acid [ RNA ] ) , c. known severely impaired lung function ( spirometry and Diffusing capacity of the lungs for carbon monoxide [ DLCO ] 50 % or less of normal and oxygen ( O2 ) saturation 88 % or less at rest on room air ) , d. active , bleeding diathesis ; e. Moderate or severe hepatic impairment ( Child - Pugh B or C )

2023-11-23 21:41:38 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 160).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
patients with progressive CLL following standard therapy who meet European Bone Marrow Transplant ( EBMT ) consensus guidelines of indications for allogeneic stem cell transplantation ; this includes patients with ( 1 ) lack of response or early relapse within 1 year of receiving a purine analog - containing treatment regimen , ( 2 ) disease relapse within 2 years of receiving a purine analog combination therapy or after other therapies such as autologous stem cell transplantation , and ( 3 ) CLL associated with tumor protein ( p)53 mutations or deletions and/or deletion ( del ) ( 17p ) requiring therapy ; patients must have chemosensitive disease with at least a partial response ( PR ) or stable disease ( SD ) with last treatment regimen

2023-11-23 21:41:41 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 168).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Has clinical response or stable disease for minimum of two months ( three cycles of every three week chemotherapy or 8 weeks of weekly regimen , etc . ) after receiving any prior chemotherapy for metastatic / recurrent disease ; a minimum of two cycles ( 6 - 8 weeks ) of chemotherapy is required to determine clinical response ; per Response Evaluation Criteria in Solid Tumors ( RECIST ) criteria 1.1 , clinical response for measurable disease is defined as complete response ( CR ) or partial response ( PR ) ; for non - measurable disease only ( i.e. bone metastasis , ascites , pleural effusion , and pathological lymph nodes > = 10 to < 15 mm short axis ) is defined as persistence of one or more non - target lesion(s ) and no increase in overall tumor burden

2023-11-23 21:41:41 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 139).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Has histological confirmation of HER2 normal breast carcinoma with a clinical diagnosis of IBC based on presence of inflammatory changes in the involved breast , including diffuse erythema and edema ( peau d'orange ) , with or without an underlying palpable mass involving the majority of the skin of the breast ; pathological evidence of dermal lymphatic invasion should be noted but is not required for diagnosis of inflammatory breast cancer regardless estrogen receptor ( ER)/progesterone receptor ( PR ) status ; OR has histological confirmation of triple negative breast carcinoma ( HER2 normal , ER / PR < 10 % ) without clinical diagnosis of IBC

2023-11-23 21:41:41 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 164).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
History of autoimmune disease , including but not limited to myasthenia gravis , myositis , autoimmune hepatitis , systemic lupus erythematosus , rheumatoid arthritis , inflammatory bowel disease , vascular thrombosis associated with antiphospholipid syndrome , Wegener 's granulomatosis , Sjgren 's syndrome , Guillain - Barr syndrome , multiple sclerosis , vasculitis , or glomerulonephritis . NOTE : patients with Grave 's disease and/or psoriasis not requiring systemic therapy within the last two years from randomization and patients with hypothyroidism ( e.g. following Hashimoto syndrome ) stable on hormone replacement are not excluded

2023-11-23 21:41:43 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 160).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients who have undergone systemic treatment , within 14 days prior to registration , with strong inhibitors of cytochrome P450 superfamily ( CYP)1A2 ( fluvoxamine , enoxacin , ciprofloxacin ) , strong inhibitors of CYP3A ( clarithromycin , telithromycin , itraconazole , voriconazole , ketoconazole , nefazodone , posaconazole ) or strong CYP3A inducers ( rifampin , rifapentine , rifabutin , carbamazepine , phenytoin , phenobarbital ) , or use of Ginkgo biloba or St. John 's wort

2023-11-23 21:41:43 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 143).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Have had known active central nervous system ( CNS ) metastases and/or carcinomatous meningitis ; subjects with previously treated brain metastases may participate provided they are stable ( without evidence of progression by imaging for at least four weeks prior to the first dose of trial treatment and any neurologic symptoms have returned to baseline ) , have no evidence of new or enlarging brain metastases , and are not using steroids for CNS involvement for at least one week prior to trial treatment ; patients with primary brain tumors are not eligible ; however , as patients are completing abiraterone therapy , they will be allowed to continue up to 10 mg / day of prednisone

2023-11-23 21:41:48 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 197).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
major depressive disorder , persistent depressive disorder , panic disorder , agoraphobia , social anxiety disorder , specific phobia , generalized anxiety disorder , obsessive - compulsive disorder , trichotillomania , excoriation disorder , hoarding disorder , body dysmorphic disorder , other specified , or unspecified obsessive - compulsive disorder , posttraumatic stress disorder , acute stress disorder , adjustment disorders , somatic symptom disorder , conversion disorder , anorexia nervosa , bulimia nervosa , binge - eating disorder , borderline personality disorder , narcissistic personality disorder , histrionic personality disorder , antisocial personality disorder , paranoid personality disorder , schizoid personality disorder , schizotypal personality disorder , avoidant personality disorder , dependent personality disorder , obsessive - compulsive personality disorder , personality disorder unspecified , depressive disorder unspecified , anxiety disorder unspecified

2023-11-23 21:41:48 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 163).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Barrier methods of contraception : Condom or Occlusive cap ( diaphragm or cervical / vault caps ) with spermicidal foam / gel / film / cream / vaginal suppository Women are considered post - menopausal and not of child bearing potential if they have had 12 months of natural ( spontaneous ) amenorrhea with an appropriate clinical profile ( e.g. age appropriate , history of vasomotor symptoms ) or have had surgical bilateral oophorectomy ( with or without hysterectomy ) or tubal ligation at least six weeks prior to enrolling . In the case of oophorectomy alone , only when the reproductive status of the woman has been confirmed by follow up hormone level assessment is she considered not of child bearing potential

2023-11-23 21:41:52 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 152).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Prior surgical or interventional procedure within 30 days of the anticipated date of the fenestrated procedure , with the exception of planned staged procedures to provide access for repair ( e.g. staged iliac conduit , thoracic endovascular aortic aneurysm repair for proximal aneurysms ) , to facilitate the procedure by allowing open reparation of a target artery not amenable to revascularization with the investigational device , such us an internal iliac artery , subclavian artery or visceral artery with early bifurcation , tortuosity or occlusive disease preventing successful placement and alignment side stents , or to treat proximal aortic aneurysms

2023-11-23 21:41:53 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 158).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Absolute Neutrophil Count ( ANC ) > /= 1,500 / microliter ; Platelets > /= 100,000 / microliter ; Hemoglobin ( Hgb ) > /= 9 g / dL ; Creatinine < /= 1.5 X upper limit of normal ( ULN ) ; Prothrombin Time ( PT ) , Partial Thromboplastin Time(PTT ) < /= 1.5 X ULN ; Total bilirubin < /= 1.5X ULN ; Alanine Transaminase ( ALT ) and Aspartate Aminotransferase ( AST ) < 1.5 X ULN ( < 5 X ULN if patient has liver metastasis )

2023-11-23 21:41:56 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 134).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Unstable cardiovascular function : symptomatic ischemia ( chest pain of cardiac origin ) , or uncontrolled clinically significant conduction abnormalities ( e.g. ventricular tachycardia on antiarrhythmics are excluded and 1st degree atrioventricular [ AV ] block or asymptomatic left anterior fascicular block [ LAFB]/right bundle branch block [ RBBB ] will not be excluded ) , or congestive heart failure ( CHF ) of New York Heart Association ( NYHA ) class > = 3 , or myocardial infarction ( MI ) within 3 months of consent date

2023-11-23 21:41:56 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 128).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patient has uncontrolled intercurrent illness including , but not limited to , symptomatic congestive heart failure , unstable angina pectoris , myocardial infarction within six months of protocol initiation , cardiac arrhythmia within six months of protocol initiation ; known inadequately controlled hypertension ; clinically significant pulmonary disease including dyspnea at rest , or patients requiring supplemental oxygen , or poor pulmonary reserve ; proteinuria or clinically significant renal function impairment ( baseline serum creatinine > 2 mg / dL ) ; or psychiatric illness / social situations that would limit compliance with study requirements

2023-11-23 21:41:56 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 137).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Trametinib can cause fetal harm when administered to a pregnant woman ; women of child - bearing potential and men must agree to use adequate contraception ( hormonal or barrier method of birth control ; abstinence ) prior to study entry , during the study participation , and for four months after the last dose of the drug ; women of child - bearing potential must have a negative serum pregnancy test within 14 days prior to registration and agree to use effective contraception throughout the treatment period and for 4 months after the last dose of study treatment ; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study , she should inform her treating physician immediately

2023-11-23 21:41:57 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
atients with fulminant liver failure , cirrhosis with evidence of portal hypertension or bridging fibrosis , alcoholic hepatitis , esophageal varices , a history of bleeding esophageal varices , hepatic encephalopathy , or correctable hepatic synthetic dysfunction evidenced by prolongation of the prothrombin time , ascites related to portal hypertension , bacterial or fungal abscess , biliary obstruction , chronic viral hepatitis with total serum bilirubin > 3 mg / dL , and symptomatic biliary disease will be excluded

2023-11-23 21:41:59 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 215).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
High risk for ovarian cancer due to familial predisposition as defined by the following : a. Known mutation in BRCA1 of BRCA2 . b. Two 1st or 2nd degree relatives of same lineage who have : two ovarian cancers ; one ovarian cancer & one pre - menopausal breast cancer ; two pre - menopausal breast cancers ; one pre - menopausal & one post - menopausal breast cancer . ( These conditions can also be met using the patient and one 1st or 2nd degree female relative . ) c. Ashkenazi Jewish descent with one 1st degree or two 2nd degree relatives with pre - menopausal breast or ovarian cancer or participant has had pre - menopausal breast cancer . d. 1st or 2nd degree male relative with breast cancer diagnosed at any age . ( First degree relative defined as children , siblings and parents . Second degree relative defined as half - siblings , aunts , uncles , nieces , nephews , grandparents , and grandchildren . )

2023-11-23 21:42:00 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 143).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
use of any of anti - retrovirals ( delavirdine ) or protease inhibitors ( ritonavir , indinavir , lopinavir / ritonavir , saquinavir , nelfinavir ) is permitted ; specifically , ritonavir and cobicistat is permitted for participants considered for the CYP3A4 - inhibitor based ART regimen arm ( Stratum A ) of the trial ; because the lists of CYP3A4 inhibitors are constantly changing , it is important to regularly consult a frequently - updated list ; medical reference texts such as the physicians ' desk reference may also provide this information ; as part of the enrollment / informed consent procedures

2023-11-23 21:42:00 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 128).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Alanine aminotransferase ( ALT ) ( serum glutamate pyruvate transaminase [ SGPT ] ) and aspartate aminotransferase ( AST ) ( serum glutamic oxaloacetic transaminase [ SGOT ] ) equal to or less than 2.5 x upper limit of normal ( ULN ) , or equal to or less than 4 x ULN ( if upon judgment of the treating physician , it is believed to be due to extramedullary hematopoiesis [ EMH ] related to myelofibrosis [ MF ] )

2023-11-23 21:42:00 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
This includes , but is not limited to : acute myeloid leukemia ( AML ) , acute lymphoblastic leukemia ( ALL ) , chronic myelogenous leukemia ( CML ) , chronic lymphocytic leukemia ( CLL ) , non - Hodgkin lymphoma ( NHL ) , Hodgkin lymphoma , multiple myeloma ( MM ) , myelodysplastic syndrome ( MDS ) , AL amyloidosis , diamond blackfan anemia , myelofibrosis or other myeloproliferative disease , sickle cell anemia , and thalassemia

2023-11-23 21:42:01 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 127).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Subjects with non - malignant pleural effusion identified on CT scan are eligible provided the effusion is not known or demonstrated to be an exudative effusion . If a pleural effusion is present , the following criteria must be met to exclude malignant involvement : A pleuracentesis is required if pleural fluid is present and visible on both CT scan and chest x - ray . Pleural fluid cytology must be negative for malignancy . Effusions that are minimal and too small for pleuracentesis as determined by the investigator will be eligible for enrollment

2023-11-23 21:42:03 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 164).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Eligible patients in the dose escalation phases of the trial must agree to biopsies of normal skin , unless they undergo optional tumor biopsies ; the mandatory biopsy requirement can be waived at the discretion of principal investigator in the event of any medical contraindication ( e.g. lidocaine allergy ) ; patients enrolled to the expanded cohorts must agree to tumor sampling ; patients on anticoagulation must be able to hold warfarin or low molecular weight heparin for a sufficient amount of time to make skin and tumor biopsies safe to perform ; PT / INR and PTT should be = < 1.5 times the institutional upper limit of normal prior to performance of skin or tumor biopsies , with values re - checked after the eligibility screen as medically indicated

2023-11-23 21:42:03 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 138).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients must not receive any other anti - cancer therapy ( cytotoxic , biologic , radiation , or hormonal other than for replacement ) while on this study except for medications that are prescribed for supportive care but may potentially have an anti - cancer effect ( i.e. megestrol acetate , bisphosphonates ) ; in addition , men receiving treatment for prostate cancer will be maintained at castrate levels of testosterone by continuation of luteinizing - releasing hormone agonists ; palliative radiation therapy ( XRT ) can be administered on study after documented discussion with the principal investigator ; for patients in expansion cohorts , this must not involve target lesions

2023-11-23 21:42:04 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 128).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Clinically significant cardiovascular disease that will be assessed on a case - by - case basis . Clinically significant cardiovascular disease usually includes one or more of the following : cardiac surgery or myocardial infarction within the last 4 weeks ; unstable angina ; acute decompensated congestive heart failure or class IV heart failure ; current significant cardiac arrhythmia or conduction disturbance , particularly those resulting in ventricular fibrillation , or causing syncope or near syncope ; uncontrolled high blood pressure ; QTc greater than 450msec ( by history for subjects with cardiac disease ) ; documented prior stroke

2023-11-23 21:42:05 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 246).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
For Arm A or D : Any number of recurrences are allowable . For Arm B : First recurrence ( only ) WHO Grade glioma . First recurrence is defined as progression following initial therapy ( i.e. , radiation  chemotherapy ) . For participants who had prior therapy with radiation or chemotherapy for a low - grade glioma , the surgical diagnosis of a high - grade glioma will be considered the first recurrence . For patients who did not get additional treatment following surgery and diagnosis of low - grade glioma , surgical diagnosis of high grade glioma will not be considered the first recurrence . Instead , progression after treatment will be considered first recurrence . For Arm C : Patients must have clinical and/or radiographic evidence of first recurrence of glioblastoma and be eligible for salvage surgical resection as deemed by the site Investigator . For Arm E : Patients must have clinical and/or radiographic evidence of recurrence of diffuse midline glioma defined as a WHO Grade IV glioma involving the pons , thalamus or spinal cord , and be eligible for salvage surgical resection as deemed by the site Investigator

2023-11-23 21:42:05 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 183).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Histologically confirmed World Health Organization Grade IV glioblastoma . WHO Grade IV gliomas will be allowed on protocol . For Arm D : Must have a WHO Grade IV glioma as per above and tumor must harbor a histone H3 K27 M mutation as evidenced by testing any tumor sample with an immunohistochemistry or DNA sequencing test . For Arm E : Must have clinical and/or radiographic evidence of a diffuse midline glioma defined as a WHO Grade IV glioma involving the brainstem , thalamus or spinal cord and be eligible for salvage surgical resection as deemed by the site Investigator . For Arm F : Must have a diffuse midline glioma , defined as a WHO Grade IV glioma involving the brainstem , thalamus or spinal cord , without the H3 K27 M mutation or with unknown H3 mutation status

2023-11-23 21:42:07 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 150).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Adequate organ function as defined by : peripheral absolute neutrophil count ( ANC ) > /= 1,000 / mm3 , platelet count > /= 100,000 / mm3 ( transfusion independent defined as not receiving platelet transfusions within a 7 day period prior to enrollment ) , hemoglobin > /= 8.0g / dl ( may receive RBC transfusions ) , renal - creatinine < /= 2 x ULN ; hepatic- bilirubin and AST < /= 5x ULN ; pulmonary : FVC > /=50 % predicted , Oxyhemoglobin saturation at rest > /=95 % ( off supplemental oxygen )

2023-11-23 21:42:07 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 141).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients of childbearing potential must have a negative pregnancy test prior to the study entry and be practicing an effective form of contraception . Sexually active subjects must agree to use medically accepted barrier methods of contraception ( e.g. , male or female condom ) during the course of the study and for 4 months after the last dose of study drug , even if oral contraceptives are also used . All subjects of reproductive potential must agree to use both a barrier method and a second method of birth control during the course of the study and for 4 months after the last dose of study drug . Pregnant women are excluded from this study because of the potential for teratogenic or abortifacient effects

2023-11-23 21:42:08 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 165).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Present use or anticipated need for cytochrome P450 ( CYP ) 3A4 - inhibiting , CYP3A4 - inducing drugs ( e.g. , ketoconazole , itraconazole , clarithromycin , atazanavir , indinavir , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , and voriconazole , rifampin , phenytoin , carbamazepine , rifabutin , rifapentin , phenobarbital , and St. John 's wort , bosentan , efavirenz , etravirine , modafinil , and nafcillin )

2023-11-23 21:42:08 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 145).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients must have histologically confirmed , metastatic or unresectable malignancy of the following types : ( a ) non - small cell lung cancer ( NSCLC ) , ( b ) triple - negative breast cancer ( TNBC ; defined by estrogen receptor [ ER ] < 1 % , progesterone receptor [ PR ] < 1 % and HER2 1 + or less by immunohistochemistry [ IHC ] ; if HER-2 expression is 2 + , a negative fluorescence in situ hybridization [ FISH ] testing is required ) ( c ) pancreatic adenocarcinoma ( PDAC ) , or ( d ) small cell lung cancer ( SCLC )

2023-11-23 21:42:09 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 173).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
For two weeks prior to first day of study drug treatment , administration of any of the following cytochrome P450 3A ( CYP3A ) inducers : phenytoin , phenobarbital , carbamazepine , rifampin , rifabutin , St. John 's Wort ; or CYP3A inhibitors : ketoconazole , itraconazole , nefazodone , ritonavir , nelfinavir , indinavir , atazanavir amprenavir , fosamprenavir , boceprevir , clarithromycin , conivaptan , lopinavir , posaconazole , saquinavir , telaprevir , telithromycin , or voriconazole

2023-11-23 21:42:10 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 131).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
OR Myelodysplastic syndrome ( MDS ) with excess blasts ( > 5 % ) and progressive disease at any time after initiation of DNA hypomethylator treatment during the past 2 years , OR failure to achieve complete or partial response or hematological improvement ( see section 12.4 ) after at least six cycles of azacytidine or four cycles of decitabine administered during the past 2 years , OR intolerance to azacytidine or decitabine . MDS patients with isolated 5q- abnormalities that meet these criteria after lenalidomide therapy and DNA hypomethylator therapy are also eligible

2023-11-23 21:42:10 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 138).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
currently receiving any of the following medications and can not be discontinued 7 days prior to starting study drug : a. Known strong inducers or inhibitors of CYP3A4/5 , including grapefruit , grapefruit hybrids , pummelos , star - fruit , and Seville oranges . b. That have a narrow therapeutic window and are predominantly metabolized through CYP3A4/5 . c. Herbal preparations / medications , dietary supplements . d. Hormone replacement therapy , topical estrogens ( including any intra - vaginal preparations ) , megestrol acetate and selective estrogen - receptor modulators ( e.g. raloxifene )

2023-11-23 21:42:10 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 167).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
femoral endarterectomy with or without patch angioplasty involving the common femoral artery and/or profunda and/or proximal superficial artery . The index groin may have undergone prior procedures ( may be inflow or outflow for existing grafts ) , but the patient must have fully healed from the prior operation . May include patients with concomitant proximal and/or distal peripheral vascular intervention . The patch may be autogenous venous or arterial or prosthetic material such as bovine pericardium , dacron or polytetrafluoroethylene ( PTFE ) . Bilateral femoral endarterectomies are eligible for enrollment . The right and left groin incision would be randomized to the same dressing which is consistent with routine clinical practice

2023-11-23 21:42:13 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 143).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
CAD ( history of MI or angina with positive stress test and not revascularizable ) ii ) LV Ejection fraction < 40 % iii ) Symptomatic CHF ( NYHC Class II , III , or IV ) c ) Pulmonary disease i ) Home oxygen therapy ii ) FEV1 < 1.2 l / s iii ) Vital capacity < 50 % predicted iv ) PaCO2 > 45 mm Hg or < 60 mm Hg d ) Renal disease i ) ESRD on dialysis ii ) eGFR < 60 e ) Prior aortic surgery f ) Hostile abdomen g ) Portal hypertension ( ascites or varices ) h ) Coagulopathy

2023-11-23 21:42:15 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 141).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
DONOR : Unrelated Umbilical Cord Blood : The UCB unit with the least HLA disparity ( with the patient ) will be selected first ( i.e. , selection priority is 6/6 match > 5/6 match > 4/6 match ) ; additional UCB units then may be selected to achieve the required cell dose ; if a second unit is required , this unit will be the unit that most closely HLA matches the patient and meets minimum size criteria outlined below of at least 1.5 x 10 ^ 7 TNC / kg ( i.e. a smaller more closely matched unit will be selected over a larger less well matched unit as long as minimum criteria are met )

2023-11-23 21:42:16 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 232).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
acute myeloid leukemia ( AML ): a. first complete remission with high - risk features defined as : ( i ) greater than 1 cycle of induction therapy required to achieve remission ; ( ii ) preceding myelodysplastic syndrome ( MDS ) ; ( iii ) presence of FLT3 mutations or internal tandem duplication or other mutations associated with poor - risk AML ( e.g. DNMT3A , TET2 ) ; ( iv ) French - American - British Classification ( FAB ) M6 or M7 classification ; ( v ) adverse cytogenetics : -5 , deletion ( del ) 5q , -7 , del7q , abnormalities involving 3q , 9q , 11q , 20q , 21q , 17 , +8 or complex karyotype ( > 3 abnormalities ) ; ( vi ) treatment - related AML , or b. second or greater remission ; patients beyond second remission have to be in complete remission ( CR ) at transplant to be eligible , or c. primary induction failure with partial response to therapy who achieve adequate cytoreduction

2023-11-23 21:42:16 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 189).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Other drugs that will be reasons for exclusion include : antimuscarinics , nifedipine , parasympathomimetics , amantadine , amoxapine , antacids , antidiarrheals , anxiolytics , hypnotics , atomexetine , bupropion , cisapride , clozapine , cyclobenzaprine , digoxin , disopyramide , dronabinol ( THC ) , ethanol , maprotilline , memantine , metoclopramide , nabilone , olanzapine , opiate agonists , orphenadrine , phenothiazines , potassium salts , quinidine , sedating H1 - blockers , topiramate , tricyclic antidepressants , erthyromycin , ketoconazole , and tegaserod

2023-11-23 21:42:18 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 130).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients with history of any autoimmune disease : inflammatory bowel disease , ( including ulcerative colitis and Crohn 's Disease ) , rheumatoid arthritis , systemic progressive sclerosis ( scleroderma ) , systemic lupus erythematosus ( SLE ) autoimmune vasculitis ( e.g. , Wegener 's Granulomatosis ) , CNS or motor neuropathy considered to be of autoimmune origin ( e.g. , Guillian - Barre Syndrome , Myasthenia Gravis , Multiple Sclerosis )

2023-11-23 21:42:19 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 127).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
History of any autoimmune disease : inflammatory bowel disease , ( including ulcerative colitis and Crohn 's Disease ) , rheumatoid arthritis , systemic progressive sclerosis ( scleroderma ) , systemic lupus erythematosus ( SLE ) autoimmune vasculitis ( e.g. , Wegener 's Granulomatosis ) , CNS or motor neuropathy considered to be of autoimmune origin ( e.g. , Guillian - Barre Syndrome , Myasthenia Gravis , Multiple Sclerosis

2023-11-23 21:42:19 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 158).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
In sustained clinical remission for the last 6 months while receiving treatment with either etanercept , infliximab , or adalimumab , and greater than or equal to 1 DMARD ( methotrexate , hydroxychloroquine , sulfasalazine , leflunomide , minocycline , cyclosporine , azathioprine , gold , penicillamine ) . DAS28 should be less than 2.6 on each visit over the preceding 6 months , with at least one visit 2 - 4 months before enrollment . If there is no visit 6 months before enrollment , the nearest visit in the 6 - 12 month period before enrollment should be considered and have a DAS28 less than 2.6

2023-11-23 21:42:20 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 330).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Mother may or may not already be taking HCQ . This latter point was discussed with Dr. Nathalie Costedoat - Chalumeau , who has published extensively on measurement of HCQ . While it might be optimal for the mothers anticipating enrollment in the study to all have been on HCQ prior to conception , this is impractical . Some may never achieve pregnancy and not want to take HCQ unless they conceive ( especially those asymptomatic ) . On the other hand , women with SLE are likely to already be on HCQ and it would limit enrollment to exclude these patients if all must initiate HCQ only at enrollment in the first trimester . Although the accepted dogma is that HCQ requires several months for maximal efficacy in treating rheumatic disease , it is unknown whether this would apply to transplacental passage or fetal levels ( which are impossible to measure ) . Dr. Costedoat - Chalumeau suggests that HCQ is probably a three compartment model which includes the circulation , tissues and cells . In the circulation , the half life is approximately 7 days and in the tissues , it is 40 days . In Dr. Costedoat - Chalumeau 's experience , steady state blood levels of HCQ are achieved in 4 - 6 weeks . Thus , dosing the mother no later than 10 weeks gestation should provide sufficient fetal exposure before the vulnerable period of CHB which is generally accepted to span 18 - 24 wks . Furthermore , the placenta has to be formed for HCQ to gain access to the fetus and it may be effective quickly for the biology we are considering

2023-11-23 21:42:21 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 174).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Mothers must have a previous child with cardiac NL , defined herein as : the presence of heart block ( 1st , 2nd , or 3rd degree ) documented by electrocardiogram ( EKG ) , echocardiogram , pacemaker , or statement in the medical record , and/or ; presence of cardiac injury , which specifically includes autopsy evidence of a mononuclear infiltrate in the endocardium , myocardium , and pericardium and/or EFE on echocardiogram always associated with cardiac dysfunction . In PITCH , we included women with a prior child with rash ; however , recent data generated from the RRNL suggest that recurrence of CHB following rash is 11 % , not 18 % [ 34 ] . Thus , inclusion of previous rash could lead to a falsely lowered recurrence rate , and will therefore be excluded

2023-11-23 21:42:26 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 188).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Systemic treatment , within 14 days before the first dose of ixazomib , with strong inhibitors of cytochrome P450 , family 1 , subfamily A , polypeptide 2 ( CYP1A2 ) ( fluvoxamine , enoxacin , ciprofloxacin ) , strong inhibitors of cytochrome P450 , family 3 , subfamily A ( CYP3A ) ( clarithromycin , telithromycin , itraconazole , voriconazole , ketoconazole , nefazodone , posaconazole ) or strong CYP3A inducers ( rifampin , rifapentine , rifabutin , carbamazepine , phenytoin , phenobarbital ) , or use of ginkgo biloba or St. John 's wort

2023-11-23 21:42:27 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 137).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients with uncontrolled intercurrent illness including , but not limited to psychiatric illness / social situations that would limit compliance with study requirements , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , myocardial infarction in the past 6 months , invasive fungal infections , or active ( acute or chronic ) or uncontrolled severe infection , liver disease such as cirrhosis , decompensated liver disease , and active and chronic hepatitis ( i.e. , quantifiable HBV - DNA and/or positive HbsAg , quantifiable HCV - RNA )

2023-11-23 21:42:27 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 161).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients with uncontrolled intercurrent illness including , but not limited to psychiatric illness / social situations that would limit compliance with study requirements , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , myocardial infarction in the past 6 months , invasive fungal infections , or active ( acute or chronic ) or uncontrolled severe infection , liver disease such as cirrhosis , decompensated liver disease , and active and chronic hepatitis ( i.e. , quantifiable hepatitis B virus [ HBV]-DNA and/or positive hepatitis B surface antigen [ HbsAg ] , quantifiable hepatitis C virus [ HCV]-ribonucleic acid [ RNA ] )

2023-11-23 21:42:27 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 128).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Current or anticipated use within 7 days prior to first dose of study drug or anticipated use during the study of the following P gp inhibitors ( amiodarone , carvedilol , clarithromycin , cobicistat , darunavir , dronedarone , erythromycin , indinavir , itraconazole , ketoconazole , lapatinib , lopinavir , propafenone , quinidine , ranolazine , ritonavir , saquinavir , telaprevir , tipranavir , verapamil , and valspodar )

2023-11-23 21:42:27 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 140).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Current activity > 2 hrs / wk of moderate intensity exercise , temporary vascular access , uncontrolled diabetes mellitus , active vasculitis , active autoimmune disease , malignancy , severe obesity ( BMI > 35 ) , alcoholism or other recreational drug use , unstable cardiac disease ( abnormal exercise test , angina , uncontrolled arrhythmias or myocardial infarction within three months ) , peripheral vascular disease ( claudication with exercise ) , lung , liver or intestinal disease , those who are medically unstable and subjects who have received anabolic , catabolic or cytotoxic medications in the past 3 months

2023-11-23 21:42:29 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 167).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
the % of positive cells will be rated : 0 points ( pts ) , 0 to 5 % ; 2 pts , 6 to 50 % ; 3 pts , 50 % ; the staining intensity will be rated as follows : 1 pt , weak intensity ; 2 pts , moderate intensity ; 3 pts , strong intensity ; pts for expression and % of positive cells will be added ; an overall score will be assigned ; tumors to be categorized into 4 groups : negative ( overall score 0 ) , 5 % cells stained , regardless of intensity ; weak expression ( overall score 1 ) , 1 - 2 pts ; moderate expression ( overall score 2 ) , 3 - 4 pts ; and strong expression ( overall score 3 ) , 5 - 6 pts ; overall H - score of 3 or above will be defined as EphA2 overexpression in tumor cells

2023-11-23 21:42:30 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 132).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Participants must have histologically or cytologically confirmed and identified resectable primary squamous cell carcinoma of the oropharynx that is HPV 16 positive or positive for any high risk HPV subtype ( i.e. , 18 , 33 , 35 , etc . ) as determined by PCR at the central laboratory . Patients must have p16 + status as determined by IHC performed or reviewed at the central laboratory prior to consent . Both p16 and HPV status must be determined prior to post - surgical adjuvant treatment assignment . Tissue from the primary site must be available for biomarker studies after surgery

2023-11-23 21:42:30 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 194).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Prior or currently active autoimmune disease requiring management with immunosuppression . This includes inflammatory bowel disease , ulcerative colitis , Crohn 's disease , systemic vasculitis , scleroderma , psoriasis , multiple sclerosis , hemolytic anemia , immune - mediated thrombocytopenia , rheumatoid arthritis , systemic lupus erythematosus , Sjorgen 's syndrome , sarcoidosis , or other rheumatologic disease or any other medical condition or use of medication ( e.g. , corticosteroids ) which might make it difficult for the patient to complete the full course of treatments or to generate an immune response to vaccines . Asthma or chronic obstructive pulmonary disease that does not require daily systemic corticosteroids is acceptable . Any patients receiving steroids should be discussed with the PI to determine if eligible

2023-11-23 21:42:33 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 181).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
1st CR with high risk features for relapse ( including history of prior malignancy treated with chemotherapy or radiotherapy , or history of myelodysplastic syndrome , myeloproliferative disorder , chronic myelomonocytic leukemia , myelodysplastic syndrome [ MDS]/myeloproliferative neoplasm [ MPN ] or other hematologic malignancy thought to have evolved to AML [ i.e. , secondary AML , ( sAML ) ] ; high risk cytogenetics at diagnosis ; fms - related tyrosine kinase 3 [ FLT3 ] mutated at diagnosis ; or presence or minimal residual disease assessed by polymerase chain reaction [ PCR ] , cytogenetics , and/or flow cytometry at time of enrollment ) 2nd CR regardless of disease characteristics at the time of diagnosis

2023-11-23 21:42:33 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 132).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Treatment with potentially hepatotoxic medications ( statins ) ; strong inhibitors of CYP3A4 ( ketoconazole , itraconazole , clarithromycin , atazanavir , nefazodone , saquinavir , telithromycin , ritonavir , indinavir , nelfinavir , voriconazole ) , or CYP3A4 inducers ( e.g. , phenytoin , carbamazepine , rifampin , rifabutin , rifapentine , phenobarbital )

2023-11-23 21:42:33 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 138).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Chronic use of agents known to affect the immune system including glucocorticoid therapy within the past 6 months , methotrexate within the past 1 year , chemotherapy of any kind ( past or present ) , immunotherapy of any kind ( past or present ) , aspirin or non - steroidal anti - inflammatory drugs ( NSAIDs ) ( within the past 2 weeks ) , statins ( within the past 1 month ) , vaccinations ( within the past 2 weeks ) , topical steroids ( within the past 2 weeks ) , and antibiotics ( within the past two weeks ) unless otherwise approved by principal investigator or PI 's designee

2023-11-23 21:42:38 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 283).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Women in the vaccine - eligible age range can not have received vaccine prior to enrollment , but will be offered HPV vaccination at the end of the study ; in brief , we are interested in the efficacy of intervention in preventing HPV in the absence of HPV vaccination , since most women worldwide who might utilize intervention will not have been vaccinated ; this includes United States ( US ) women in the vaccine catch - up 19 - 26 year old age group ( beyond the age groups eligible for Vaccines for Children- funded vaccination ) who have so far had very low ( < 10 % ) vaccine uptake ; it also includes the entire group of US women > 26 years of age ; moreover , it includes women of all ages in developing countries , who most need an HPV prevention strategy , but may never be vaccinated ; it should be noted that delaying vaccination in women 19 - 26 years of age by one year is safe and reasonable , since there is insufficient data to establish a recommendation for or against universal vaccination in this age group as concluded by an American Cancer Society expert panel , which includes the Principal Investigator ( PI ) of this protocol , Dr. Mark Einstein ; it is anticipated that if the intervention gel is efficacious , HPV vaccinated women would need to be studied in a similar future trial with power analysis taking into account vaccine effectiveness as well

2023-11-23 21:42:39 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 151).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Cytology report with a High Grade Squamous Intra Epithelial Lesion HSIL or have histologically proven CIN 2/3 or CIN 3 diagnosed by cervical biopsy between 2 and 8 weeks prior to enrollment . For a patient to be eligible , the Cytology report must state High Grade Squamous Intra Epithelial Lesion HSIL or the pathology report must clearly state CIN 2/3 or CIN 3 or must state moderate - severe dysplasia , moderate severe dyskaryosis , severe dysplasia , or severe dyskaryosis . Patients with a diagnosis of CIN 2 alone or moderate dysplasia or dyskaryosis alone are not eligible for this study

2023-11-23 21:42:39 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 131).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients taking the following concurrent medications : astemizole , cisapride , salmeterol , alfuzosin , terfinadine , amiodarone , midazolam , quinadine , ergot derivatives , pimozide , rifampin , triazolam , warfarin , azithromycin , carbamezpine , cyclosporine , didanosine , fluticasone propionate , phenobarbital , phenytoin , trazadone , sirolimus , tacrolimus , and St. John 's wart

2023-11-23 21:42:39 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 141).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Using any medication known to have adverse effects on motor or cognitive function , including monoamine oxidase inhibitors , sympathomimetics , antipsychotic agents , modafinil , oxybutynin , tricyclic antidepressants , cholinesterase inhibitors and anticonvulsants other than gabapentin and pregabalin . The following are permitted if the patient has been on a stable dose for at least 6 weeks : short acting benzodiazepines ( qhs administration only ) , anti - spasmodics , selective serotonin reuptake inhibitors and serotonin - norepinephrine reuptake inhibitors

2023-11-23 21:42:39 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 188).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Current use of or anticipated requirement during the study of prohibited medication(s ) ( any investigational drug(s ) , Other anti - cancer therapy ( chemotherapy , radiation therapy , immunotherapy , biologic therapy , or hormone therapy other than for replacement ) , AR antagonists ( e.g. , bicalutamide , flutamide , nilutamide ) , 5 - alpha reductase inhibitors ( e.g. , finasteride , dutasteride ) , Androgens ( e.g. , testosterone , dihydroepiandrosterone ) , Herbal medication(s ) that may affect PSA levels ( e.g. , saw palmetto ) , Other herbal medications including , but not limited to : St. John 's wort , kava , ephedra ( ma huang ) , gingko biloba , yohimbe and ginseng )

2023-11-23 21:42:40 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 262).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Patients who have any severe and/or uncontrolled medical conditions such as : a ) unstable angina pectoris , symptomatic congestive heart failure , myocardial infarction = < 6 months prior to start of everolimus , serious uncontrolled cardiac arrhythmia , or any other clinically significant cardiac disease ; b ) symptomatic congestive heart failure of New York Heart Association class III or IV ; c ) active ( acute or chronic ) or uncontrolled severe infection ( not responding to antibiotics ) , liver disease such as cirrhosis , decompensated liver disease , and active and chronic hepatitis ( i.e. quantifiable hepatitis B virus - deoxyribonucleic acid [ HBV - DNA ] and/or positive hepatitis B surface antigen [ HbsAg ] , quantifiable hepatitis C virus - ribonucleic acid [ HCV - RNA ] ) ; d ) known severely impaired lung function ( spirometry and diffusing capacity of the lung for carbon monoxide [ DLCO ] 50 % or less of normal and oxygen [ O2 ] saturation 88 % or less at rest on room air ) ; e ) active , bleeding diathesis

2023-11-23 21:42:41 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 203).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Women of child - bearing potential ( WOCBP ) , defined as women physiologically capable of becoming pregnant , must use one additional highly effective methods of contraception in addition to the LIUD during the study and 8 weeks after ; acceptable effective contraception methods include combo of the following : a ) barrier methods of contraception : condom or occlusive cap ( diaphragm or cervical / vault caps ) with spermicidal foam / gel / film / cream/ vaginal suppository ; b ) total abstinence or ; c ) male / female sterilization ; women are considered post - menopausal and not of child - bearing potential if they have had 12 months of natural ( spontaneous ) amenorrhea with an appropriate clinical profile ( e.g. age appropriate , history of vasomotor symptoms ) or have had surgical bilateral oophorectomy ( with or without hysterectomy ) or tubal ligation > six weeks prior to randomization

2023-11-23 21:42:41 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 132).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
The effects of AT13387 on the developing human fetus are unknown ; for this reason and because paclitaxel are known to be teratogenic ; women of child - bearing potential and men must agree to use adequate contraception prior to study entry , for the duration of study participation and 3 months after completion of study treatment administration ; adequate contraception includes methods such as oral contraceptives , double barrier method ( condom plus spermicide or diaphragm ) , or abstaining from sexual intercourse ; should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study , she should inform her treating physician immediately

2023-11-23 21:42:41 - Transformer_NER - INFO - 
************** Example ************
input tokens: ['[CLS]', 'any', 'surgical', 'therapy', 'in', 'the', 'area', 'of', 'the', 'oral', 'cavity', 'or', 'ph', '##ary', '##nx', 'within', 'the', 'last', '2', 'weeks', '[SEP]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]']
input ids: [101, 2151, 11707, 7242, 1999, 1996, 2181, 1997, 1996, 8700, 17790, 2030, 6887, 5649, 26807, 2306, 1996, 2197, 1016, 3134, 102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
label: [1, 3, 30, 31, 3, 3, 3, 3, 3, 3, 3, 3, 3, 2, 2, 3, 3, 33, 32, 32, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
mask: [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
segment ids: [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
guards: [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 12, 12, 13, 14, 15, 16, 17, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
***********************************
            
2023-11-23 21:42:41 - Transformer_NER - INFO - 
************** Example ************
input tokens: ['[CLS]', 'any', 'tumor', 'stage', ',', 'any', 'n', ',', 'm', '##0', '[SEP]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]']
input ids: [101, 2151, 13656, 2754, 1010, 2151, 1050, 1010, 1049, 2692, 102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
label: [1, 3, 10, 3, 3, 3, 3, 3, 3, 2, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
mask: [1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
segment ids: [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
guards: [0, 1, 2, 3, 4, 5, 6, 7, 8, 8, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
***********************************
            
2023-11-23 21:42:41 - Transformer_NER - INFO - 
************** Example ************
input tokens: ['[CLS]', 'eco', '##g', 'performance', 'status', '0', 'or', '1', '[SEP]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]', '[PAD]']
input ids: [101, 17338, 2290, 2836, 3570, 1014, 2030, 1015, 102, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
label: [1, 14, 2, 15, 15, 25, 3, 33, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
mask: [1, 1, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
segment ids: [0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
guards: [0, 1, 1, 2, 3, 4, 5, 6, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0]
***********************************
            
2023-11-23 21:42:43 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 170).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
MRI contraindications including : cardiac pacemaker , metal fragments in eyes / skin / body ( shrapnel ) , aortic / aneurysm clips , prosthesis , by - pass surgery / coronary artery clips , hearing aid , heart valve replacement , shunt ( ventricular or spinal ) , electrodes , metal plates / pins / screws/ wires , or neuro / bio - stimulators ( TENS unit ) , persons who have ever been a professional metal worker / welder , history of eye surgery / eyes washed out because of metal , vision problems uncorrectable with lenses , inability to lie still on one 's back for 60 - 120 minutes ; prior neurosurgery ; tattoos or cosmetic makeup with metal dyes , unwillingness to remove body piercings , and pregnancy

2023-11-23 21:42:45 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 171).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Caution should be exercised when administering paclitaxel ( Taxol ) concomitantly with medicines known to inhibit ( e.g. ketoconazole and other imidazole antifungals , erythromycin , fluoxetine , gemfibrozil , cimetidine , ritonavir , saquinavir , indinavir and nelfinavir ) OR induce ( e.g. rifampicin , carbamazepine , phenytoin , efavirenz and nevirapine ) either CYP2C8 or CYP3A4 . Based on the in vitro data and SimCYP simulations , selumetinib is considered unlikely to perpetrate clinically significant drug - drug interaction via inhibition or induction of CYP enzymes

2023-11-23 21:42:46 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 160).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Anti - Convulsants : carbamazepine , Phenobarbital , Anti - Convulsant : phenytoin , Anti - Mycobacterial : rifabutin , PDE5 Inhibitors : sildenafil , vardenafil , tadalafil , HMG - CoA : Reductase Inhibitors : atorvastatin , rosuvastatin , Immuno - suppressants : cyclosporine , tacrolimus , sirolimus , Narcotic Analgesic : methadone , Oral Contraceptive : ethinyl estradiol , Macrolide Antibiotic : azithromycin , Inhaled / nasal steroid fluticasone , Antidepressant : trazodone

2023-11-23 21:42:48 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 162).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
NHL : No clinical evidence of disease or disease - related symptoms ; Typically FDG - avid lymphomas : a post - treatment residual mass of any size is permitted as long as it is PET negative ; Variably FDG - avid lymphoma / FDG avidity unknown : all lymph nodes normal size by CT ; Spleen and liver non - palpable and without nodules ; If pretreatment bone marrow biopsy was positive , repeat bone marrow biopsy must be negative ; if morphologically indeterminate , immunohistochemistry should be negative If pretreatment bone marrow biopsy was positive , repeat bone marrow biopsy must be negative ; if morphologically indeterminate , immunohistochemistry should be negative

2023-11-23 21:42:48 - Transformer_NER - WARNING - 
Sentence after tokenization is too long (expect less than 126 but got 132).
You have to increase max_seq_length to make sure every sentence after tokenization is not longer than the max_seq_length.
Or you can further split you long sentences into shorter ones. We will defaultly segment the sentence to two or more seqs with length as (~max_seq_len * n + rest).
The extra long sentence: 
Current or history of treatment with medications that may cause significant weight gain , within 1 month prior to screening for this trial , including systemic corticosteroids ( except for a short course of treatment , i.e. , 7- 10 days ) , tri - cyclic antidepressants , atypical antipsychotic and mood stabilizers ( e.g. , imipramine , amitryptiline , mirtazapine , paroxetine , phenelzine , clorpromazine , thioridazine , clozapine , olanzapine , valproic acid and its derivatives , and lithium )

2023-11-23 21:42:54 - Transformer_NER - INFO - ***** Running training *****
2023-11-23 21:42:54 - Transformer_NER - INFO -   Num data points = 5043
2023-11-23 21:42:54 - Transformer_NER - INFO -   Num Epochs = 20.0
2023-11-23 21:42:54 - Transformer_NER - INFO -   Instantaneous batch size per GPU = 8
2023-11-23 21:42:54 - Transformer_NER - INFO -   Gradient Accumulation steps = 1
2023-11-23 21:42:54 - Transformer_NER - INFO -   Total optimization steps = 100860.0
2023-11-23 21:42:54 - Transformer_NER - INFO -   Training steps (number of steps between two evaluation on dev) = 1000
2023-11-23 21:42:54 - Transformer_NER - INFO - ******************************
